BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649. [PMID: 4541913 DOI: 10.1002/bjs.1800600817] [Cited by in Crossref: 5129] [Cited by in F6Publishing: 4785] [Article Influence: 104.7] [Reference Citation Analysis]
Number Citing Articles
1 Nishi H, Takahashi T, Ichikawa H, Matsumiya G, Matsuda H, Sawa Y. Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart failure. Gen Thorac Cardiovasc Surg 2009;57:357-62. [DOI: 10.1007/s11748-008-0387-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bugianesi E, Tangerman A, Ronchi M, Bianchi G, Marchesini G. Transamination of methionine after loading in patients with cirrhosis. Journal of Hepatology 1996;24:95-100. [DOI: 10.1016/s0168-8278(96)80192-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011;31:980-4. [PMID: 21733087 DOI: 10.1111/j.1478-3231.2011.02465.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
4 Zhu AX, Finn RS, Mulcahy M, Gurtler J, Sun W, Schwartz JD, Dalal RP, Joshi A, Hozak RR, Xu Y, Ancukiewicz M, Jain RK, Nugent FW, Duda DG, Stuart K. A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer. Clin Cancer Res. 2013;19:6614-6623. [PMID: 24088738 DOI: 10.1158/1078-0432.ccr-13-1442] [Cited by in Crossref: 99] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
5 Papatheodoridis GV, Hadziyannis ES, Deutsch M, Hadziyannis SJ. Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial. Am J Gastroenterology 2002;97:2063-70. [DOI: 10.1111/j.1572-0241.2002.05923.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
6 Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005;22:1079-89. [PMID: 16305721 DOI: 10.1111/j.1365-2036.2005.02691.x] [Cited by in Crossref: 221] [Cited by in F6Publishing: 213] [Article Influence: 13.8] [Reference Citation Analysis]
7 Huang YS, Lee SD, Deng JF, Wu JC, Lu RH, Lin YF, Wang YJ, Lo KJ. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol 1993;19:140-7. [PMID: 8301034 DOI: 10.1016/s0168-8278(05)80187-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Caraceni P, Viola A, Piscitelli F, Giannone F, Berzigotti A, Cescon M, Domenicali M, Petrosino S, Giampalma E, Riili A. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Liver Int. 2010;30:816-825. [PMID: 19840245 DOI: 10.1111/j.1478-3231.2009.02137.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
9 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
10 Keung ACF, Eller MG, Weir SJ. Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction. The Journal of Clinical Pharmacology 1998;38:517-24. [DOI: 10.1002/j.1552-4604.1998.tb05789.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
11 Harris M, Angel JB, Baril JG, Rachlis A, Trottier B. Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults. Can J Infect Dis Med Microbiol 2009;20:e24-34. [PMID: 20514155 DOI: 10.1155/2009/658125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Bernardi E, Carbone G, Dentali F; Advisory Board of the Italian Society of Emergency Medicine (SIMEU). How to manage patients on rivaroxaban in the emergency department: a statement of the Italian society of emergency medicine advisory board. Eur J Emerg Med 2016;23:320-9. [PMID: 26351974 DOI: 10.1097/MEJ.0000000000000322] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Artinyan A, Marshall CL, Balentine CJ, Albo D, Orcutt ST, Awad SS, Berger DH, Anaya DA. Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis. Cancer 2012;118:3494-500. [PMID: 22170573 DOI: 10.1002/cncr.26682] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Ann Surg Oncol 2007;14:1170-81. [PMID: 17195904 DOI: 10.1245/s10434-006-9299-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
15 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164-1175. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
16 Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 2011;26:281-9. [DOI: 10.1007/s11011-011-9260-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
17 Efird LM, Mishkin DS, Berlowitz DR, Ash AS, Hylek EM, Ozonoff A, Reisman JI, Zhao S, Jasuja GK, Rose AJ. Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease. Circ Cardiovasc Qual Outcomes 2014;7:461-7. [DOI: 10.1161/circoutcomes.113.000817] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
18 Donnez J, Arriagada P, Marciniak M, Larrey D. Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program. Expert Opin Drug Saf 2018;17:1225-32. [PMID: 30460871 DOI: 10.1080/14740338.2018.1550070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
19 Brookman LJ, Rolan PE, Benjamin IS, Palmer KR, Wyld PJ, Lloyd P, Flesch G, Waldmeier F, Sioufi A, Mullins F. Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther 1997;62:272-8. [DOI: 10.1016/s0009-9236(97)90029-1] [Cited by in Crossref: 64] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
20 Liu CH, Hsu SJ, Liang CC, Tsai FC, Lin JW, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH, Chen DS. Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis. Radiology. 2008;248:132-139. [PMID: 18483230 DOI: 10.1148/radiol.2481071257] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
21 Ghent CN, Wall WJ. The lidocaine monoethylglycinexylidide test of liver function. Liver Transpl Surg 1996;2:242-5. [PMID: 9346657 DOI: 10.1002/lt.500020313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
22 Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing Concepts of Cirrhotic Coagulopathy. Am J Gastroenterol. 2017;112:274-281. [PMID: 27801884 DOI: 10.1038/ajg.2016.498] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 15.0] [Reference Citation Analysis]
23 Bucak İÖ, Baki S. Diagnosis of liver disease by using CMAC neural network approach. Expert Systems with Applications 2010;37:6157-64. [DOI: 10.1016/j.eswa.2010.02.112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
24 Shuto T, Hirohashi K, Kubo S, Tanaka H, Hamba H, Kubota D, Kinoshita H. Delayed hepatic resection for ruptured hepatocellular carcinoma. Surgery. 1998;124:33-37. [PMID: 9663249 DOI: 10.1016/s0039-6060(98)70072-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
25 Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest. 2001;119:1489-1497. [PMID: 11348958 DOI: 10.1378/chest.119.5.1489] [Cited by in Crossref: 119] [Cited by in F6Publishing: 98] [Article Influence: 5.7] [Reference Citation Analysis]
26 Broomé U, Eriksson LS, Sundin U, Sundqvist KG. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand J Gastroenterol. 1992;27:124-128. [PMID: 1561525 DOI: 10.3109/00365529209165431] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
27 Conn HO. Hyperammonia and Cerebral Herniation: Is an Abnormality of Ammonia Metabolism Responsible? American Journal of Gastroenterology 1999;94:3646. [DOI: 10.1111/j.1572-0241.1999.03646.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Yao FY, Bass NM. Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol 2000;33:301-7. [PMID: 10952248 DOI: 10.1016/s0168-8278(00)80371-2] [Cited by in Crossref: 137] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
29 Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, Padrini R, Palatini P. Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis. Clinical Chemistry 2002;48:850-8. [DOI: 10.1093/clinchem/48.6.850] [Cited by in Crossref: 111] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
30 Desautels SG, Slivka A, Schoen RE, Carr B, Rabinovitz M, Silverman W. Gastrointestinal bleeding in cirrhotic patients with hepatocellular carcinoma undergoing intrahepatic artery chemotherapy. Gastrointest Endosc 1997;46:430-4. [PMID: 9402117 DOI: 10.1016/s0016-5107(97)70036-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol 2006; 12(24): 3866-3873 [PMID: 16804972 DOI: 10.3748/wjg.v12.i24.3866] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
32 de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease. Clin Lab Haematol. 1991;13:127-135. [PMID: 1934923 DOI: 10.1111/j.1365-2257.1991.tb00261.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
33 Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 1994;20:917-23. [PMID: 7927233 DOI: 10.1002/hep.1840200421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
34 Iwamoto M, Hanley WD, Petry AS, Friedman EJ, Kost JT, Breidinger SA, Lasseter KC, Robson R, Lunde NM, Wenning LA, Stone JA, Wagner JA. Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics. Antimicrob Agents Chemother 2009;53:1747-52. [PMID: 19223645 DOI: 10.1128/AAC.01194-08] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
35 Moon YW, Kim YS, Kwon SY, Kim SY, Lim SJ, Park YS. Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. J Korean Med Sci 2007;22:223-6. [PMID: 17449928 DOI: 10.3346/jkms.2007.22.2.223] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
36 Kubo S, Tanaka H, Takemura S, Yamamoto S, Hai S, Ichikawa T, Kodai S, Shinkawa H, Sakaguchi H, Tamori A. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol Res. 2007;37:94-100. [PMID: 17300703 DOI: 10.1111/j.1872-034x.2007.00013.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
37 Parisi A, Desiderio J, Trastulli S, Castellani E, Pasquale R, Cirocchi R, Boselli C, Noya G. Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12:270-277. [PMID: 23742772 DOI: 10.1016/S1499-3872(13)60044-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
38 Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MDC, Vilana R, Rodés J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution: Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized, Controlled Trial. Hepatology 1998;27:1578-83. [DOI: 10.1002/hep.510270617] [Cited by in Crossref: 376] [Cited by in F6Publishing: 358] [Article Influence: 19.8] [Reference Citation Analysis]
39 Li MX, Bi XY, Li ZY, Huang Z, Han Y, Zhou JG, Zhao JJ, Zhang YF, Zhao H, Cai JQ. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015;94:e2133. [PMID: 26656342 DOI: 10.1097/MD.0000000000002133] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
40 Tsutsumi M, Urashima S, Nakase K, Takada A. Changes in laminin content in livers of patients with alcoholic liver disease. Liver 1995;15:324-31. [DOI: 10.1111/j.1600-0676.1995.tb00693.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol. 2002;97:2855-2860. [PMID: 12425560 DOI: 10.1111/j.1572-0241.2002.07053.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
42 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Yamamoto T, Ikebe T, Kinoshita H. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999;86:793-8. [DOI: 10.1002/(sici)1097-0142(19990901)86:5<793::aid-cncr14>3.0.co;2-k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
43 Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell'Era A, Fabris F, Salerno F, Mannucci PM. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006;44:440-445. [PMID: 16871542 DOI: 10.1002/hep.21266] [Cited by in Crossref: 241] [Cited by in F6Publishing: 196] [Article Influence: 15.1] [Reference Citation Analysis]
44 Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther. 1989;40:439-474. [PMID: 2646653 DOI: 10.1016/0163-7258(89)90088-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 1.8] [Reference Citation Analysis]
45 Granito A, Facciorusso A, Sacco R, Bartalena L, Mosconi C, Cea UV, Cappelli A, Antonino M, Modestino F, Brandi N, Tovoli F, Piscaglia F, Golfieri R, Renzulli M. TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma. J Pers Med 2021;11:1041. [PMID: 34683182 DOI: 10.3390/jpm11101041] [Reference Citation Analysis]
46 Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Liver Int. 2010;30:1033-1042. [PMID: 20492502 DOI: 10.1111/j.1478-3231.2010.02255.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
47 Arthur MJ, Tanner AR, Patel C, Wright R, Renwick AG, George CF. Pharmacology of propranolol in patients with cirrhosis and portal hypertension. Gut 1985;26:14-9. [PMID: 3965362 DOI: 10.1136/gut.26.1.14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
48 Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. The American Journal of Surgery 2012;203:101-6. [DOI: 10.1016/j.amjsurg.2010.09.030] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
49 Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc. 2006;64:855-864. [PMID: 17140886 DOI: 10.1016/j.gie.2006.03.007] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
50 Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648-655. [PMID: 6732310 DOI: 10.1097/00000658-198406000-00003] [Cited by in Crossref: 347] [Cited by in F6Publishing: 263] [Article Influence: 9.1] [Reference Citation Analysis]
51 Ito T, Ishigami M, Morooka H, Yamamoto K, Imai N, Ishizu Y, Honda T, Nishimura D, Tada T, Yasuda S, Toyoda H, Kumada T, Fujishiro M. The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC. Sci Rep 2020;10:17812. [PMID: 33082429 DOI: 10.1038/s41598-020-74732-3] [Reference Citation Analysis]
52 Pompili M, Riccardi L, Covino M, Barbaro B, Di Stasi C, Orefice R, Gasbarrini G, Rapaccini GL. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int. 2005;25:954-961. [PMID: 16162152 DOI: 10.1111/j.1478-3231.2005.01135.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
53 Gentile S, Turco S, Torella R. Diabetes mellitus after liver transplantation: a possible relation with the nutritional status. Diabetes Res Clin Pract 1998;41:203-5. [PMID: 9829350 DOI: 10.1016/s0168-8227(98)00058-8] [Reference Citation Analysis]
54 Tian X, Shi Y, Hu J, Wang G, Zhang C. Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding. Hepatol Int 2013;7:636-44. [DOI: 10.1007/s12072-013-9433-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
55 Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, Palazzi J, Sarano H, Pozzoli L, Sanchez R, Giordano R. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: Long-term hemodynamic and renal effects. Hepatology 1993;18:477-84. [DOI: 10.1002/hep.1840180302] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
56 Pan JJ, Javle M, Thinn MM, Hsueh CT, Hsueh CT. Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma. Hepat Med 2010;2:147-55. [PMID: 24367212 DOI: 10.2147/HMER.S7123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
57 Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48:945-951. [PMID: 18433921 DOI: 10.1016/j.jhep.2008.02.015] [Cited by in Crossref: 173] [Cited by in F6Publishing: 171] [Article Influence: 12.4] [Reference Citation Analysis]
58 Wang J, Zhang Z, Yan X, Li M, Xia J, Liu Y, Chen Y, Jia B, Zhu L, Zhu C, Huang R, Wu C. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Digestive and Liver Disease 2019;51:1172-8. [DOI: 10.1016/j.dld.2019.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
59 Atsukawa M, Tsubota A, Hatano M, Kondo C, Shioda K, Ohno H, Kawano T, Hayama K, Arai T, Nakagawa-Iwashita A, Itokawa N, Kaneko K, Yoshida Y, Koeda M, Okubo T, Yamamoto T, Yamamoto T, Taniai N, Yoshida H, Kanazawa H, Shimizu W, Iwakiri K. Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization. Hepatol Res 2020;50:1244-54. [PMID: 32822521 DOI: 10.1111/hepr.13560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
60 Dingemanse J, van Giersbergen PL. Influence of mild liver impairment on the pharmacokinetics of tezosentan, a drug excreted unchanged into bile. Br J Clin Pharmacol 2004;57:344-8. [PMID: 14998431 DOI: 10.1046/j.1365-2125.2003.01987.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
61 Facciuto ME, Rochon C, Pandey M, Rodriguez-Davalos M, Samaniego S, Wolf DC, Kim-Schluger L, Rozenblit G, Sheiner PA. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009;11:398-404. [PMID: 19768144 DOI: 10.1111/j.1477-2574.2009.00073.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Morgan MY, Hawley KE. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology. 1987;7:1278-1284. [PMID: 3315932 DOI: 10.1002/hep.1840070617] [Cited by in Crossref: 75] [Cited by in F6Publishing: 53] [Article Influence: 2.2] [Reference Citation Analysis]
63 Cao C, Wang C. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism. Clin Exp Med 2020;20:569-76. [PMID: 32712720 DOI: 10.1007/s10238-020-00646-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Tan CK, Gores GJ, Steers JL, Porayko MK, Hay JE, Rakela J, Wiesner RH, Krom RA. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc 1994;69:509-14. [PMID: 7514702 DOI: 10.1016/s0025-6196(12)62240-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis. Hepatology 1993;18:847-52. [PMID: 8406358 DOI: 10.1002/hep.1840180415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
66 Saravanan R, Nayar M, Gilmore IT, Smart H, Mcwilliams RG, Rowlands PC, Evans J, Murphy M, Gould D, Taylor S, Sutton R, Lombard MG. Transjugular intrahepatic portosystemic stent shunt: 11 years?? experience at a regional referral centre: . European Journal of Gastroenterology & Hepatology 2005;17:1165-71. [DOI: 10.1097/00042737-200511000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
67 Skluzacek PA, Szewc RG, Nolan CR 3rd, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis. 2003;42:1169-1176. [PMID: 14655188 DOI: 10.1053/j.ajkd.2003.08.017] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
68 Tasu JP, Rocher L, PEletier G, Kuoch V, Kulh E, Miquel A, Buffet C, BlEry M. Hepatic venous pressure gradients measured by duplex ultrasound. Clin Radiol 2002;57:746-52. [PMID: 12169287 DOI: 10.1053/crad.2002.0951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
69 Saleh S, Becker C, Frey R, Mück W. Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment. Pulm Circ 2016;6:S75-85. [PMID: 27162631 DOI: 10.1086/685647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
70 Meng HC, Lin HC, Tsai YT, Lee FY, Liao DM, Hsia HC, Lin WJ, Chang TT, Lay CS, Wang SS. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J Gastroenterol Hepatol 1994;9:148-53. [PMID: 8003648 DOI: 10.1111/j.1440-1746.1994.tb01235.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
71 Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, Kim MJ, Kim KW. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Clin Radiol. 2012;67:148-156. [PMID: 21920517 DOI: 10.1016/j.crad.2011.08.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
72 Ronsoni MF, Lazzarotto C, Fayad L, Silva MC, Nogueira CL, Bazzo ML, Narciso-schiavon JL, Dantas-corrêa EB, Schiavon LDL. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis. Annals of Hepatology 2013;12:456-63. [DOI: 10.1016/s1665-2681(19)31009-9] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
73 Cai C, Chen H, Lu M, Chen G. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B: . Chinese Medical Journal 2008;121:2065-9. [DOI: 10.1097/00029330-200810020-00023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
74 Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150:835-853. [PMID: 26795574 DOI: 10.1053/j.gastro.2015.12.041] [Cited by in Crossref: 781] [Cited by in F6Publishing: 771] [Article Influence: 130.2] [Reference Citation Analysis]
75 Srivastava M, Rungta S, Dixit VK, Shukla SK, Singh TB, Jain AK. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective. Antiviral Res. 2013;100:300-305. [PMID: 24012998 DOI: 10.1016/j.antiviral.2013.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
76 Imperiale TF, Said AT, Cummings OW, Born LJ. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol 2000;95:2328-32. [PMID: 11007237 DOI: 10.1111/j.1572-0241.2000.02322.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 3.4] [Reference Citation Analysis]
77 Fujita T, Ito K, Tanabe M, Yamatogi S, Sasai H, Matsunaga N. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol. 2008;19:333-341. [PMID: 18295691 DOI: 10.1016/j.jvir.2007.10.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
78 Chao YC, Wang LS, Hsieh TY, Chu CW, Chang FY, Chu HC. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis. Am J Gastroenterol. 2000;95:2958-2964. [PMID: 11051375 DOI: 10.1111/j.1572-0241.2000.02328.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 2.9] [Reference Citation Analysis]
79 Bui K, She F, Sostek M. The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol. J Clin Pharmacol 2014;54:1368-74. [PMID: 24945932 DOI: 10.1002/jcph.348] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
80 Smith BS, Yogaratnam D, Levasseur-Franklin KE, Forni A, Fong J. Introduction to drug pharmacokinetics in the critically ill patient. Chest. 2012;141:1327-1336. [PMID: 22553267 DOI: 10.1378/chest.11-1396] [Cited by in Crossref: 130] [Cited by in F6Publishing: 110] [Article Influence: 13.0] [Reference Citation Analysis]
81 Tian X, Wang Q, Zhang C, Liu F, Cui Y, Liu F, Liu J. Modified Percutaneous Transhepatic Variceal Embolization With 2-Octylcyanoacrylate for Bleeding Gastric Varices: Long-Term Follow-Up Outcomes. American Journal of Roentgenology 2011;197:502-9. [DOI: 10.2214/ajr.10.6005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
82 Pozzi M, Grassi G, Ratti L, Favini G, Dell’Oro R, Redaelli E, Calchera I, Boari G, Mancia G. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis. Am J Gastroenterol. 2005;100:1110-1116. [PMID: 15842586 DOI: 10.1111/j.1572-0241.2005.41060.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
83 Mccollum K. A6. Appetite and nutritional intake in patients with chronic liver disease: Abstracts. Journal of Human Nutrition and Dietetics 2000;13:363-71. [DOI: 10.1046/j.1365-277x.2000.00001-7.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Shu CC, Hsu CL, Wei YF, Lee CY, Liou HH, Wu VC, Yang FJ, Lin HH, Wang JY, Chen JS, Yu CJ, Lee LN. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay. Medicine (Baltimore) 2016;95:e3813. [PMID: 27258523 DOI: 10.1097/MD.0000000000003813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
85 Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G; Liver Transplantation Group. MELD and other predictors of survival after liver transplantation. Clin Transplant 2009;23:220-7. [PMID: 19210688 DOI: 10.1111/j.1399-0012.2008.00943.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
86 Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kuzuya T, Nonogaki K, Shimizu J. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma. J Gastroenterol Hepatol 2005;20:963-5. [PMID: 15946154 DOI: 10.1111/j.1440-1746.2005.03841.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
87 Giannini E, Fasoli A, Chiarbonello B, Malfatti F, Romagnoli P, Botta F, Testa E, Polegato S, Fumagalli A, Testa R. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002;16:717-725. [PMID: 11929389 DOI: 10.1046/j.1365-2036.2002.01200.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
88 Morcuende A, Navarrete F, Nieto E, Manzanares J, Femenía T. Inflammatory Biomarkers in Addictive Disorders. Biomolecules 2021;11:1824. [PMID: 34944470 DOI: 10.3390/biom11121824] [Reference Citation Analysis]
89 Wu Y, Cao Y, Xu K, Zhu Y, Qiao Y, Wu Y, Chen J, Li C, Zeng R, Ge G. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis. Cell Death Dis 2021;12:163. [PMID: 33558482 DOI: 10.1038/s41419-021-03443-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Tomikawa M, Hashizume M, Akahoshi T, Shimabukuro R, Gotoh N, Ohta M, Sugimachi K. Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices. J Gastroenterol Hepatol. 2002;17:77-80. [PMID: 11895557 DOI: 10.1046/j.1440-1746.2002.02656.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
91 Uemura M, Buchholz U, Kojima H, Keppler A, Hafkemeyer P, Fukui H, Tsujii T, Keppler D. Cysteinyl leukotrienes in the urine of patients with liver diseases. Hepatology 1994;20:804-12. [PMID: 7927219 DOI: 10.1002/hep.1840200406] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
92 Weil A, Martin P, Smith R, Oliver S, Langmuir P, Read J, Molz K. Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment: . Clinical Pharmacokinetics 2010;49:607-18. [DOI: 10.2165/11534330-000000000-00000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
93 Biggins SW, Feng S. In a MELD-based economy, how can we fight off inflation? Liver Transpl 2007;13:2-4. [DOI: 10.1002/lt.21008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
94 Kamath PS, Mookerjee RP. Individualized care for portal hypertension: Not quite yet. Journal of Hepatology 2015;63:543-5. [DOI: 10.1016/j.jhep.2015.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
95 Horsmans Y, Zhou J, Liudmila M, Golor G, Shibolet O, Quinlan M, Emotte C, Boss H, Castro H, Sellami D, Preston RA. Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group Study. Clin Pharmacokinet 2018;57:345-54. [PMID: 28577129 DOI: 10.1007/s40262-017-0560-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
96 Kang SH, Kim do Y, Jeon SM, Ahn SH, Park JY, Kim SU, Kim JK, Lee KS, Chon CY, Han KH. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol. 2012;24:849-856. [PMID: 22495400 DOI: 10.1097/meg.0b013e3283535c34] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
97 Donaghy AJ, Delhanty PJ, Ho KK, Williams R, Baxter RC. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. Journal of Hepatology 2002;36:751-8. [DOI: 10.1016/s0168-8278(02)00049-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
98 Chuang W, Liu H, Chang W. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion. Cancer 1990;65:926-30. [DOI: 10.1002/1097-0142(19900215)65:4<926::aid-cncr2820650418>3.0.co;2-u] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
99 Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7:350-391. [PMID: 19406039 DOI: 10.6004/jnccn.2009.0027] [Cited by in Crossref: 299] [Cited by in F6Publishing: 324] [Article Influence: 23.0] [Reference Citation Analysis]
100 El-badrawy MK, Ali RE, Yassen AM, Elela MAA, Elmorsey RA. Delayed-onset chest infections in liver transplant recipients: a prospective study. Egypt J Bronchol 2016;10:147-54. [DOI: 10.4103/1687-8426.184362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Santambrogio R, Barabino M, Scifo G, Costa M, Giovenzana M, Opocher E. Effect of Age (over 75 Years) on Postoperative Complications and Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J Gastrointest Surg 2017;21:657-65. [DOI: 10.1007/s11605-016-3354-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
102 Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S. Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia. Ther Clin Risk Manag 2019;15:269-74. [PMID: 30804674 DOI: 10.2147/TCRM.S186106] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]. JHEP Rep 2021;3:100353. [PMID: 34693237 DOI: 10.1016/j.jhepr.2021.100353] [Reference Citation Analysis]
104 Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, Lien HC, Yang SS. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52:160-167. [PMID: 10922085 DOI: 10.1067/mge.2000.104976] [Cited by in Crossref: 177] [Cited by in F6Publishing: 150] [Article Influence: 8.0] [Reference Citation Analysis]
105 Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. Ther Drug Monit. 2018;40:663-674. [PMID: 30192314 DOI: 10.1097/ftd.0000000000000561] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
106 Finn RS, Ryoo BY, Merle P, Kudo M, Bouattour M, Lim HY, Breder V, Edeline J, Chao Y, Ogasawara S, Yau T, Garrido M, Chan SL, Knox J, Daniele B, Ebbinghaus SW, Chen E, Siegel AB, Zhu AX, Cheng AL;  KEYNOTE-240 investigators. Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. J Clin Oncol. 2020;38:193-202. [PMID: 31790344 DOI: 10.1200/jco.19.01307] [Cited by in Crossref: 317] [Cited by in F6Publishing: 219] [Article Influence: 105.7] [Reference Citation Analysis]
107 Wang X, Qiao ZW, Zhou ZJ, Zhuang PJ, Zheng S. Postoperative morphine concentration in infants with or without biliary atresia and its association with hepatic blood flow. Anaesthesia 2014;69:583-90. [DOI: 10.1111/anae.12624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Forner A, Díaz-gonzález Á, Liccioni A, Vilana R. Prognosis prediction and staging. Best Practice & Research Clinical Gastroenterology 2014;28:855-65. [DOI: 10.1016/j.bpg.2014.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
109 von Hentig N, Lötsch J. Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults. Antimicrob Agents Chemother 2009;53:3524-7. [PMID: 19528289 DOI: 10.1128/AAC.00025-09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Lee YJ, Hah YJ, Kang YN, Kang KJ, Hwang JS, Chung WJ, Cho KB, Park KS, Kim ES, Seo HY, Kim MK, Park KG, Jang BK. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS One 2013;8:e81540. [PMID: 24282606 DOI: 10.1371/journal.pone.0081540] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
111 Okamura Y, Ashida R, Yamamoto Y, Ito T, Sugiura T, Uesaka K. FIB-4 Index is a Predictor of Background Liver Fibrosis and Long-Term Outcomes After Curative Resection of Hepatocellular Carcinoma. Ann Surg Oncol 2016;23:467-74. [DOI: 10.1245/s10434-016-5377-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
112 Bianchi G, Marchesini G, Vilstrup H, Fabbri A, De Mitri MS, Zoli M, Pisiél E. Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: A simplified method. Hepatology 1991;13:460-6. [DOI: 10.1002/hep.1840130313] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
113 Johansson U, Wahren J, Siw Eriksson L. Splanchnic and peripheral glucose metabolism in cirrhosis. Journal of Hepatology 1994;20:760-7. [DOI: 10.1016/s0168-8278(05)80147-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
114 Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int. 2003;23:243-248. [PMID: 12895263 DOI: 10.1034/j.1600-0676.2003.00833.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 5.5] [Reference Citation Analysis]
115 Sugimoto H, Kaneko T, Takeda S, Inoue S, Nakao A. The use of quantitative Doppler ultrasonography to predict posthepatectomy complications on the basis of hepatic hemodynamic parameters. Surgery 2002;132:431-40. [DOI: 10.1067/msy.2002.126407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
116 Kulisevsky J, Conill J, Avila A, Pujol J, Balanzó J, Capdevila A. Abnormalities of the Bereitschaftspotential and MRI pallidal signal in non-encephalopathic cirrhotic patients. Electroencephalogr Clin Neurophysiol 1995;94:425-31. [PMID: 7607096 DOI: 10.1016/0013-4694(94)00331-e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
117 Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A, Miranda A, Portincasa P, Carbonara V, Palasciano G. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis. 2010;42:200-204. [PMID: 19502117 DOI: 10.1016/j.dld.2009.05.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
118 Kruszynska YT, Meyer-alber A, Wollen N, Mcintyre N. Energy expenditure and substrate metabolism after oral fructose in patients with cirrhosis. Journal of Hepatology 1993;19:241-51. [DOI: 10.1016/s0168-8278(05)80578-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
119 Wu WC, Chen YT, Chen PH, Su CW, Huang WM, Yang TC, Li SY, Chen TJ, Lin HC, Lee FY, Hou MC. Low air temperature increases the risk of oesophageal variceal bleeding: a population and hospital-based case-crossover study in Taiwan. Liver Int 2016;36:856-64. [PMID: 26235679 DOI: 10.1111/liv.12930] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Lun Y, Liu H, Jiang H, Li X, Xin S, Zhang J. Low Serum-Free Testosterone Concentration in Chinese Male Patients with Uncomplicated Acute Type B Aortic Dissection. Ann Vasc Surg 2021;75:324-31. [PMID: 33549782 DOI: 10.1016/j.avsg.2021.01.084] [Reference Citation Analysis]
121 Huang YS, Chiang JH, Wu JC, Chang FY, Lee SD. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol. 2002;97:1223-1227. [PMID: 12014732 DOI: 10.1111/j.1572-0241.2002.05709.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
122 Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD. Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis. 2004;19:431-445. [PMID: 15554433 DOI: 10.1023/b:mebr.0000043987.09022.e3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
123 Kudo M. Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm. Liver Cancer 2017;6:185-8. [PMID: 28626730 DOI: 10.1159/000462199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
124 Arns P, Branch R. Prescribing for patients with liver disease. Baillière's Clinical Gastroenterology 1989;3:109-30. [DOI: 10.1016/0950-3528(89)90049-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
125 Samir N, Matboli M, El-Tayeb H, El-Tawdi A, Hassan MK, Waly A, El-Akkad HAE, Ramadan MG, Al-Belkini TN, El-Khamisy S, El-Asmar F. Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer. J Cell Biochem 2018;119:6869-81. [PMID: 29737552 DOI: 10.1002/jcb.26884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
126 Cillo U, Vitale A, Navaglia F, Basso D, Montin U, Bassanello M, D'Amico F, Ciarleglio FA, Brolese A, Zanus G, De Pascale V, Plebani M, D'Amico DF. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma. World J Gastroenterol 2005;11:6920-5. [PMID: 16437593 DOI: 10.3748/wjg.v11.i44.6920] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
127 Martial LC, Brüggemann RJ, Schouten JA, van Leeuwen HJ, van Zanten AR, de Lange DW, Muilwijk EW, Verweij PE, Burger DM, Aarnoutse RE, Pickkers P, Dorlo TP. Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure. Clin Pharmacokinet 2016;55:723-33. [PMID: 26649870 DOI: 10.1007/s40262-015-0347-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
128 Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy. 2000;20:318-329. [PMID: 10730687 DOI: 10.1592/phco.20.4.318.34881] [Cited by in Crossref: 280] [Cited by in F6Publishing: 234] [Article Influence: 12.7] [Reference Citation Analysis]
129 Romero A, Pérez-arellano JL, González-villarón L, Brock JH, Bellido JLM, Castro SD. Effect of transferrin concentration on bacterial growth in human ascitic fluid from cirrhotic and neoplastic patients. Eur J Clin Invest 1993;23:699-705. [DOI: 10.1111/j.1365-2362.1993.tb01289.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
130 Kovacs SJ, Ting L, Praestgaard J, Sunkara G, Sun H, Stein DS, Tanaka SK, Villano S. An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline. Antimicrob Agents Chemother 2020;64:e01650-20. [PMID: 32839218 DOI: 10.1128/AAC.01650-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Bianchi G, Bugianesi E, Ronchi M, Fabbri A, Zoli M, Marchesini G. Glutathione kinetics in normal man and in patients with liver cirrhosis. Journal of Hepatology 1997;26:606-13. [DOI: 10.1016/s0168-8278(97)80426-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
132 Butt AS, Hamid S, Wadalawala AA, Ghufran M, Javed AA, Farooq O, Ahmed B, Ul Haq T, Jafri W. Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma. BMC Res Notes 2013;6:137. [PMID: 23566475 DOI: 10.1186/1756-0500-6-137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
133 Frea S, Bovolo V, Pidello S, Canavosio FG, Botta M, Bergerone S, Gaita F. Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome? Int J Cardiol 2015;195:53-60. [PMID: 26022800 DOI: 10.1016/j.ijcard.2015.05.061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
134 Matiollo C, Rateke ECM, de Oliveira KG, Turnes BL, da Silva TE, Maccali C, Latini AS, Narciso-Schiavon JL, Schiavon LL. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis. Dig Liver Dis 2020;52:753-60. [PMID: 32434738 DOI: 10.1016/j.dld.2020.03.024] [Reference Citation Analysis]
135 Inoue Y, Kitada K, Fujii K, Kagota S, Tomioka A, Yamaguchi T, Yokohama K, Ohama H, Hamamoto H, Ishii M, Osumi W, Tsuchimoto Y, Terazawa T, Ogura T, Masubuchi S, Yamamoto M, Imoto A, Asai A, Komeda K, Fukunishi S, Hirokawa F, Goto M, Tanaka K, Okuda J, Higuchi K, Uchiyama K. The Relationship Between the Number of Ports and Surgical Outcomes in Laparoscopic Hepatectomy. Surg Laparosc Endosc Percutan Tech 2020;30:85-90. [PMID: 31876888 DOI: 10.1097/SLE.0000000000000750] [Reference Citation Analysis]
136 Siringo S, Bolondi L, Sofia S, Hermida RC, Gramantieri L, Gaiani S, Piscaglia F, Carbone C, Misitano B, Corinaldesi R. Circadian occurrence of variceal bleeding in patients with liver cirrhosis. J Gastroenterol Hepatol. 1996;11:1115-1120. [PMID: 9034929 DOI: 10.1111/j.1440-1746.1996.tb01838.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
137 Hung HH, Chang CJ, Hou MC, Liao WC, Chan CC, Huang HC, Lin HC, Lee FY, Lee SD. Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: a randomized controlled trial. J Hepatol 2012;56:1025-32. [PMID: 22266602 DOI: 10.1016/j.jhep.2011.12.021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
138 Trieb M, Rainer F, Stadlbauer V, Douschan P, Horvath A, Binder L, Trakaki A, Knuplez E, Scharnagl H, Stojakovic T, Heinemann Á, Mandorfer M, Paternostro R, Reiberger T, Pitarch C, Amorós A, Gerbes A, Caraceni P, Alessandria C, Moreau R, Clària J, Marsche G, Stauber RE. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol 2020;73:113-20. [PMID: 32061870 DOI: 10.1016/j.jhep.2020.01.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
139 Ohnishi A, Murakami S, Akizuki S, Mochizuki J, Echizen H, Takagi I. In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease. J Clin Pharmacol. 2005;45:1221-1229. [PMID: 16239354 DOI: 10.1177/0091270005280787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
140 Hwang S, Lin H, Chang C, Lee F, Lu C, Hsia H, Wang S, Lee S, Tsai Y, Lo K. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. Journal of Hepatology 1992;16:320-5. [DOI: 10.1016/s0168-8278(05)80663-4] [Cited by in Crossref: 76] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
141 Assouad J, Barthes Fle P, Shaker W, Souilamas R, Riquet M. Recurrent pleural effusion complicating liver cirrhosis. Ann Thorac Surg 2003;75:986-9. [PMID: 12645728 DOI: 10.1016/s0003-4975(02)04548-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
142 Albarmawi A, Czock D, Gauss A, Ehehalt R, Lorenzo Bermejo J, Burhenne J, Ganten TM, Sauer P, Haefeli WE. CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores. Br J Clin Pharmacol. 2014;77:160-169. [PMID: 23772874 DOI: 10.1111/bcp.12182] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
143 Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, Wen Y, Zou H. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC. World J Surg Oncol. 2018;16:208. [PMID: 30326907 DOI: 10.1186/s12957-018-1500-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
144 Urbain D, Muls V, Thys O, Ham HR. Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. J Hepatol. 1995;22:179-183. [PMID: 7790706 DOI: 10.1016/0168-8278(95)80426-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
145 Beaudry P, Hadengue A, Callebert J, Gaudin C, Soliman H, Moreau R, Launay JM, Lebrec D. Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology. 1994;20:800-803. [PMID: 7523265 DOI: 10.1002/hep.1840200405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
146 Rachakonda V, Borhani AA, Dunn MA, Andrzejewski M, Martin K, Behari J. Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS One 2016;11:e0159142. [PMID: 27583675 DOI: 10.1371/journal.pone.0159142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
147 Massicotte L, Carrier FM, Karakiewicz P, Hevesi Z, Thibeault L, Nozza A, Bilodeau M, Roy A, Denault AY. Impact of MELD Score-Based Organ Allocation on Mortality, Bleeding, and Transfusion in Liver Transplantation: A Before-and-After Observational Cohort Study. J Cardiothorac Vasc Anesth 2019;33:2719-25. [PMID: 31072701 DOI: 10.1053/j.jvca.2019.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
148 Zhang CQ, Liu FL, Liang B, Xu HW, Xu L, Feng K, Liu ZC. A modified percutaneous transhepatic varices embolization with 2-octyl cyanoacrylate in the treatment of bleeding esophageal varices. J Clin Gastroenterol. 2009;43:463-469. [PMID: 19142166 DOI: 10.1097/mcg.0b013e31817ff90f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
149 Palmieri C, Macpherson IR. A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairment. ESMO Open 2021;6:100162. [PMID: 34098229 DOI: 10.1016/j.esmoop.2021.100162] [Reference Citation Analysis]
150 Kim JE, Jeon JP, No HC, Choi JH, Lee SH, Ryu KH, Kim ES. The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation. Korean J Anesthesiol 2011;60:408-15. [PMID: 21738843 DOI: 10.4097/kjae.2011.60.6.408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
151 Kovács M, Pák P, Németh A, Pák G, Fehér J, Rácz I. [Role of capsule endoscopy in patients with portal hypertension and obscure gastrointestinal bleeding]. Orv Hetil 2007;148:1491-7. [PMID: 17675276 DOI: 10.1556/OH.2007.28170] [Reference Citation Analysis]
152 Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of Superparamagnetic Iron Oxide–Enhanced and Gadobenate Dimeglumine–Enhanced Dynamic MRI for Detection of Small Hepatocellular Carcinomas. American Journal of Roentgenology 2004;182:1217-23. [DOI: 10.2214/ajr.182.5.1821217] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
153 D’Amico G, Politi F, Morabito A, D’Antoni A, Guerrera D, Giannuoli G, Traina M, Vizzini G, Pasta L, Pagliaro L. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial. Hepatology. 1998;28:1206-1214. [PMID: 9794903 DOI: 10.1002/hep.510280507] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
154 Sieders E, Peeters PMJG, Tenvergert EM, de Jong KP, Porte RJ, Zwaveling JH, Bijleveld CMA, Slooff MJH. PROGNOSTIC FACTORS FOR LONG-TERM ACTUAL PATIENT SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN CHILDREN: . Transplantation 2000;70:1448-53. [DOI: 10.1097/00007890-200011270-00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
155 Álvarez-Lerma F, Grau S, López C, Jiménez JD, Trasmonte MV, Nieto M, Parra G, Herrero E; Grupo de Estudio de Micafungina en UCI. [Patients treated with micafungin during their stay in intensive care unit]. Med Intensiva 2015;39:467-76. [PMID: 25798955 DOI: 10.1016/j.medin.2014.10.010] [Reference Citation Analysis]
156 Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver. 2002;22 Suppl 2:5-13. [PMID: 12220296 DOI: 10.1034/j.1600-0676.2002.00001.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 6.8] [Reference Citation Analysis]
157 Ali ME, El-Badawy O, Afifi NA, Eldin AS, Hassan EA, Halby HM, El-Mokhtar MA. Role of T-Helper 9 Cells in Chronic Hepatitis C-Infected Patients. Viruses 2018;10:E341. [PMID: 29937515 DOI: 10.3390/v10070341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
158 Mpabanzi L, Deutz N, Hayes PC, Dejong CH, Olde Damink SW, Jalan R. Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients. Aliment Pharmacol Ther. 2012;35:921-928. [PMID: 22360430 DOI: 10.1111/j.1365-2036.2012.05044.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
159 Wei L, Ye Z, Bao Z, Xu X, Lin X, Chen L. Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading. Clinics (Sao Paulo) 2020;75:e1670. [PMID: 32935822 DOI: 10.6061/clinics/2020/e1670] [Reference Citation Analysis]
160 Shalimar D, Vadiraja PK, Nayak B, Thakur B, Das P, Datta Gupta S, Panda SK, Acharya SK. Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856-864. [PMID: 26519215 DOI: 10.1111/jgh.13213] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
161 Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt LA. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother 2007;51:417-22. [PMID: 17158943 DOI: 10.1128/AAC.00851-06] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
162 Liu F, Wei Y, Wang W, Chen K, Yan L, Wen T, Zhao J, Xu M, Li B. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection. PLoS One. 2012;7:e48932. [PMID: 23145027 DOI: 10.1371/journal.pone.0048932] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
163 Ferro D, Quintarelli C, Saliola M, Alessandri C, Basili S, Bonavita M, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1993;7:59-62. [DOI: 10.1016/0268-9499(93)90056-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
164 Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M, Obermayer-Pietsch B, Stauber RE. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012;32:845-851. [PMID: 22222013 DOI: 10.1111/j.1478-3231.2011.02735.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
165 Mikuriya Y, Tashiro H, Kobayashi T, Kuroda S, Abe T, Hashimoto M, Ohdan H. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. Langenbecks Arch Surg 2015;400:471-6. [PMID: 25744657 DOI: 10.1007/s00423-015-1295-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
166 Inoue Y, Suzuki Y, Ota M, Fujii K, Kawaguchi N, Hirokawa F, Hayashi M, Uchiyama K. Short- and Long-Term Results of Laparoscopic Parenchyma-Sparing Hepatectomy for Small-Sized Hepatocellular Carcinoma: A Comparative Study Using Propensity Score Matching Analysis. The American Surgeon 2018;84:230-7. [DOI: 10.1177/000313481808400230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Shangraw RE, Rabkin JM, Lopaschuk GD. Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis, transplantation, and dichloroacetate. Am J Physiol 1998;274:G569-77. [PMID: 9530159 DOI: 10.1152/ajpgi.1998.274.3.G569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
168 Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Chou TC, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML. Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection. Clin Transl Gastroenterol 2018;9:166. [PMID: 29961754 DOI: 10.1038/s41424-018-0033-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
169 Kato M, Ishizuka H, Taguchi T, Shiosakai K, Kamiyama E, Sata M, Yoshida T. Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study. Adv Ther 2018;35:1239-50. [DOI: 10.1007/s12325-018-0739-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
170 Zekanovic D, Ljubicic N, Boban M, Nikolic M, Delic-Brkljacic D, Gacina P, Klarin I, Turcinov J. Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis. Dig Dis Sci. 2010;55:458-466. [PMID: 19277866 DOI: 10.1007/s10620-009-0760-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
171 Bian S, Tian XG, Hu JH, Wang GC, Zhang CQ. Percutaneous transhepatic variceal embolization combined with endoscopic ligation for the prevention of variceal rebleeding. J Dig Dis. 2013;14:388-395. [PMID: 23432941 DOI: 10.1111/1751-2980.12049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
172 Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology. 1994;20:1173-1178. [PMID: 7927249 DOI: 10.1002/hep.1840200511] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
173 Hashimoto M, Sasaki K, Moriyama J, Matsuda M, Watanabe G. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery. 2013;153:727-731. [PMID: 22705249 DOI: 10.1016/j.surg.2012.03.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
174 Ohfuji S, Fukushima W, Sasaki Y, Tamori A, Kurai O, Kioka K, Maeda K, Maeda A, Hirota Y. Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients. Liver Int 2014;34:700-6. [PMID: 23981146 DOI: 10.1111/liv.12295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
175 Hashizume M, Ohta M, Ueno K, Tanoue K, Kitano S, Sugimachi K. Endoscopic ligation of esophageal varices compared with injection sclerotherapy: a prospective randomized trial. Gastrointest Endosc. 1993;39:123-126. [PMID: 8495830 DOI: 10.1016/s0016-5107(93)70050-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
176 Samada Suarez M, Hernández Perera J, Ramos Robaina L, Barroso Márquez L, González Rapado L, Valdés MC, Rivero HH, Abdo Cuza A, Valdés AR, Pérez Bernal J, Bernardos A. Factors That Predict Survival in Patients With Cirrhosis Considered for Liver Transplantation. Transplantation Proceedings 2008;40:2965-7. [DOI: 10.1016/j.transproceed.2008.08.110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
177 Fortea JI, Puente Á, Ezcurra I, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J. Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey. Dig Liver Dis 2019;51:95-103. [PMID: 29960901 DOI: 10.1016/j.dld.2018.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
178 Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-ferrer J, Singh D, Mattos AZ, Carrilho F, Debes JD. Sorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis From the South American Liver Research Network. Journal of Clinical Gastroenterology 2019;53:464-9. [DOI: 10.1097/mcg.0000000000001085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
179 Grosso G, di Francesco F, Vizzini G, Mistretta A, Pagano D, Echeverri GJ, Spada M, Basile F, Gridelli B, Gruttadauria S. The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience. Transplant Proc. 2012;44:1298-1302. [PMID: 22664004 DOI: 10.1016/j.transproceed.2012.01.131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
180 Suzuki K, Takikawa Y. Biomarkers Of Malnutrition In Liver Cirrhosis. In: Lakshman R, Preedy V, Ross Watson R, Srirajaskanthan R, editors. Nutrition, Diet Therapy, and the Liver. CRC Press; 2009. pp. 203-15. [DOI: 10.1201/9781420085501.sec3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
181 Gao F, Sun L, Ye X, Liu Y, Liu H, Geng M, Li X, Yang X, Li Y, Wang R. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Eur J Gastroenterol Hepatol. 2017;29:669-678. [PMID: 28195876 DOI: 10.1097/MEG.0000000000000854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Romano M, Meise KS, Suozzo R, Sessa G, Persico M, Coffey RJ. Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. Dig Dis Sci. 1995;40:263-267. [PMID: 7851187 DOI: 10.1007/bf02065407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
183 Aggarwal A, Aggarwal N, Nagral A, Jankharia G, Bhatt M. A novel Global Assessment Scale for Wilson's Disease (GAS for WD). Mov Disord 2009;24:509-18. [PMID: 19115420 DOI: 10.1002/mds.22231] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
184 Yang L, Fang F, Ou D, Wu W, Zeng Z, Wu F. Solitary Large Hepatocellular Carcinoma: A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection. Annals of Surgery 2009;249:118-23. [DOI: 10.1097/sla.0b013e3181904988] [Cited by in Crossref: 140] [Cited by in F6Publishing: 75] [Article Influence: 10.8] [Reference Citation Analysis]
185 Zhou M, Chan EW, Hai JJ, Wong CK, Lau YM, Huang D, Lam CC, Tam CCF, Wong YTA, Yung SYA, Chan KWK, Feng Y, Tan N, Chen JY, Yung CY, Lee KL, Choi CW, Lam H, Ng A, Fan K, Jim MH, Yiu KH, Yan BP, Siu CW. Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study. BMJ Open 2020;10:e038194. [PMID: 32978200 DOI: 10.1136/bmjopen-2020-038194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
186 Luque S, Hope W, Sorli L, Muñoz-Bermudez R, Campillo N, Barceló-Vidal J, Álvarez-Lerma F, Horcajada JP, Masclans-Enviz JR, Neely M, Grau S. Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity. Antimicrob Agents Chemother 2021;65:e02490-20. [PMID: 33820765 DOI: 10.1128/AAC.02490-20] [Reference Citation Analysis]
187 Montes-de-Oca M, Blanco MJ, Marquez M, Soto MJ, Fernandez-Gutiérrez C, Rodriguez-Ramos C, Giron-Gonzalez JA. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Liver Int. 2011;31:850-858. [PMID: 21645216 DOI: 10.1111/j.1478-3231.2011.02505.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
188 Toesca DA, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Practical Radiation Oncology 2017;7:173-82. [DOI: 10.1016/j.prro.2016.10.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
189 Božin T, Mustapić S, Bokun T, Patrlj L, Rakić M, Aralica G, Kujundžić M, Trkulja V, Grgurević I. Albi Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to Palbi and Meld Liver Function Scores. Acta Clin Croat 2018;57:292-300. [PMID: 30431722 DOI: 10.20471/acc.2018.57.02.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
190 Xu L, Wu J, Lu W, Yang C, Liu H. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Transplant Proc. 2019;51:3338-3346. [PMID: 31732203 DOI: 10.1016/j.transproceed.2019.08.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
191 Lebrec D, Poynard T, Capron JP, Hillon P, Geoffroy P, Roulot D, Chaput JC, Rueff B, Benhamou JP. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol. 1988;7:118-125. [PMID: 3053888 DOI: 10.1016/s0168-8278(88)80515-4] [Cited by in Crossref: 110] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
192 Kim T, Kim BW, Wang HJ, Lee HY, Won JH, Kim J, Hu XG, Sim J, Bang JB, Kim YB. Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. Ann Surg 2016;264:330-8. [PMID: 26587849 DOI: 10.1097/SLA.0000000000001460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
193 Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med. 2009;47:305-310. [PMID: 19676142 DOI: 10.1515/cclm.2009.083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
194 Moreau R, Hadengue A, Pussard E, Soubrane O, Sogni P, Gaudin C, Lebrec D. Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis. Hepatology 1991;14:1035-9. [DOI: 10.1002/hep.1840140615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
195 Dipasquale A, Marinello A, Santoro A. A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario. J Hepatocell Carcinoma 2021;8:241-51. [PMID: 33884259 DOI: 10.2147/JHC.S270532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Katayama K. Clinical significance of the latency period of abnormal ammonia metabolism in chronic liver disease: Proposal of a new concept. Hepatol Res 2021. [PMID: 34679199 DOI: 10.1111/hepr.13724] [Reference Citation Analysis]
197 Zhang LJ, Qi R, Zhong J, Xu Q, Zheng G, Lu GM. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study. PLoS One. 2012;7:e42824. [PMID: 22912746 DOI: 10.1371/journal.pone.0042824] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
198 Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC 2nd, McMasters KM, Cho CS, Winslow ER, Wood WC, Staley CA 3rd. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg. 2011;212:638-648; discussion 648-650. [PMID: 21463803 DOI: 10.1016/j.jamcollsurg.2011.01.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 7.5] [Reference Citation Analysis]
199 Park HJ, Seo KI, Kim SJ, Lee SU, Yun BC, Han BH, Shin DH, Choi YI, Moon HH. Effectiveness of Albumin-bilirubin Score as a Predictor of Post-hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. Korean J Gastroenterol 2021;77:115-22. [PMID: 33658474 DOI: 10.4166/kjg.2020.148] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Radosavljevic M, Temsch E, Hammer J, Pfeffel F, Mayer G, Renner F, Pidlich J, Muller C. Elevated levels of serum carbohydrate deficient transferrin are not specific for alcohol abuse in patients with liver disease. J Hepatol. 1995;23:706-711. [PMID: 8750170 DOI: 10.1016/0168-8278(95)80037-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
201 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis. JHEP Rep 2021;3:100287. [PMID: 34041469 DOI: 10.1016/j.jhepr.2021.100287] [Reference Citation Analysis]
202 Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44:994-1002. [PMID: 16510203 DOI: 10.1016/j.jhep.2005.10.034] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 6.3] [Reference Citation Analysis]
203 Hu J, Zhao H, Lou D, Gao H, Yang M, Zhang X, Jia H, Li L. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis 2018;18:577. [PMID: 30445927 DOI: 10.1186/s12879-018-3488-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
204 Hsieh CB, Yu CY, Tzao C, Chu HC, Chen TW, Hsieh HF, Liu YC, Yu JC. Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection. Eur J Surg Oncol 2006;32:72-6. [PMID: 16246517 DOI: 10.1016/j.ejso.2005.09.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
205 Yen D, Hu S, Chen L, Liu K, Kao W, Tsai J, Chern C, Lee C. Arterial oxygen desaturation during emergent nonsedated upper gastrointestinal endoscopy in the emergency department. The American Journal of Emergency Medicine 1997;15:644-7. [DOI: 10.1016/s0735-6757(97)90178-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
206 Uslu N, Saltik-temizel IN, Demir H, Usta Y, Özen H, Gürakan F, Yüce A, Koçak N. Bone mineral density in children with cirrhosis. J Gastroenterol 2006;41:873-7. [DOI: 10.1007/s00535-006-1864-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-9, 1979.e1-3. [PMID: 21376047 DOI: 10.1053/j.gastro.2011.02.058] [Cited by in Crossref: 265] [Cited by in F6Publishing: 241] [Article Influence: 24.1] [Reference Citation Analysis]
208 Kielbasa W, Tesfaye E, Luffer-Atlas D, Mitchell MI, Turik MA. The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor. Eur J Clin Pharmacol 2013;69:2011-9. [PMID: 23955175 DOI: 10.1007/s00228-013-1572-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
209 Cipriani F, Fantini C, Ratti F, Lauro R, Tranchart H, Halls M, Scuderi V, Barkhatov L, Edwin B, Troisi RI, Dagher I, Reggiani P, Belli G, Aldrighetti L, Abu Hilal M. Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients? Surg Endosc. 2018;32:617-626. [PMID: 28717870 DOI: 10.1007/s00464-017-5711-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
210 Lau WY, Yu SC, Lai EC, Leung TW. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg. 2006;202:155-168. [PMID: 16377509 DOI: 10.1016/j.jamcollsurg.2005.06.263] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
211 Aubé C, Oberti F, Korali N, Namour M, Loisel D, Tanguy J, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maïga MY, Penneau-fontbonne D, Caron C, Calès P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. Journal of Hepatology 1999;30:472-8. [DOI: 10.1016/s0168-8278(99)80107-x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
212 Chun HJ, Hyun JH. A new method of endoscopic variceal ligation-injection sclerotherapy (EVLIS) for gastric varices. Korean J Intern Med 1995;10:108-19. [PMID: 7495768 DOI: 10.3904/kjim.1995.10.2.108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
213 Chapman WC, Garcia-Aroz S, Vachharajani N, Fowler K, Saad N, Lin Y, Wellen J, Tan B, Khan AS, Doyle MB. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions. J Am Coll Surg. 2017;224:610-621. [PMID: 28069527 DOI: 10.1016/j.jamcollsurg.2016.12.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
214 Perumpail BJ, Li AA, Cholankeril G, Kumari R, Ahmed A. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017;9. [PMID: 29027963 DOI: 10.3390/nu9101114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
215 Ludwig D, Schwarting K, Korbel CM, Brüning A, Schiefer B, Stange EF. The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis. J Hepatol 1998;28:631-8. [PMID: 9566832 DOI: 10.1016/s0168-8278(98)80287-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
216 Fialla AD, Thiesson HC, Bie P, Schaffalitzky de Muckadell OB, Krag A. Internal dysregulation of the renin system in patients with stable liver cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 2017;77:298-309. [DOI: 10.1080/00365513.2017.1308546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
217 Sansoé G, Silvano S, Mengozzi G, Todros L, Smedile A, Touscoz G, Rosina F, Rizzetto M. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. J Hepatol 2004;40:417-23. [PMID: 15123355 DOI: 10.1016/j.jhep.2003.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
218 Iqbal MJ, Wilkinson ML, Forbes A, Corbishley TP, Williams R. Preponderance of serum and intra-hepatic 5 alpha-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels. J Hepatol 1986;3:304-9. [PMID: 3031151 DOI: 10.1016/s0168-8278(86)80482-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
219 Gao L, Ramzan I, Baker B. Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function †‡. British Journal of Anaesthesia 2002;88:764-70. [DOI: 10.1093/bja/88.6.764] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
220 Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, Meyers WC. Hepatocellular carcinoma. Br J Surg. 1998;85:1319-1331. [PMID: 9782009 DOI: 10.1046/j.1365-2168.1998.00865.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 4.9] [Reference Citation Analysis]
221 Mostafa TM, Ibrahim OM, Badra GA, Abdallah MS. Role of pentoxifylline and sparfloxacin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients. ISRN Gastroenterol 2014;2014:595213. [PMID: 24729879 DOI: 10.1155/2014/595213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
222 Lafleur M, Labelle F, Lemoyne M, Gélinas MD. Nutritional assessment in chronic liver disease patients: A comparison between skeletal muscle function and standard nutritional parameters. Nutrition Research 1996;16:545-53. [DOI: 10.1016/0271-5317(96)00033-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
223 Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World J Gastroenterol 2013; 19(21): 3207-3216 [PMID: 23745022 DOI: 10.3748/wjg.v19.i21.3207] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
224 Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13(29): 3996-4001 [PMID: 17663517 DOI: 10.3748/wjg.v13.i29.3996] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
225 Hassouna MM, Naguib M, Radwan EM, Abdel-Samiee M, Estaphan S, Abdelsameea E. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2020;21:3357-63. [PMID: 33247696 DOI: 10.31557/APJCP.2020.21.11.3357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Starczewska MH, Mon W, Shirley P. Anaesthesia in patients with liver disease. Current Opinion in Anaesthesiology 2017;30:392-8. [DOI: 10.1097/aco.0000000000000470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
227 Rosman AS, Basu P, Galvin K, Lieber CS. Utility of Carbohydrate-Deficient Transferrin as a Marker of Relapse in Alcoholic Patients. Alcoholism Clin Exp Res 1995;19:611-6. [DOI: 10.1111/j.1530-0277.1995.tb01556.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
228 Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, Kim HS, Hahn T, Kim BI, Heo J, An H, Tak WY, Baik SK, Han KH, Hwang JS, Park SH, Cho M, Um SH. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60:954-963. [PMID: 24415445 DOI: 10.1002/hep.27006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 73] [Article Influence: 13.1] [Reference Citation Analysis]
229 Le Treut YP, Castellani P, Pol B, Campan P, Hardwigsen J, Botta-Fridlund D. [Liver transplantation in the adult: who and when to transplant?]. Rev Med Interne 1998;19:892-903. [PMID: 9887457 DOI: 10.1016/s0248-8663(99)80062-9] [Reference Citation Analysis]
230 Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S, Iacono C. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg. 2007;11:143-149. [PMID: 17390163 DOI: 10.1007/s11605-006-0082-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
231 Thompson BW, Casali RE, Read RC, Campbell GS. Results of interposition "H" grafts for portal hypertension. Ann Surg 1978;187:515-22. [PMID: 306227 DOI: 10.1097/00000658-197805000-00009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
232 Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, Deguchi A, Ishikawa T, Imai M, Ochi H, Joko K, Shimada N, Tajiri K, Hirooka M, Koizumi Y, Hiasa Y, Tanaka J. Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic. Journal of Gastroenterology and Hepatology 2018;34:1066-73. [DOI: 10.1111/jgh.14564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
233 Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC;  European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962-1968. [PMID: 23389867 DOI: 10.1002/hep.26306] [Cited by in Crossref: 174] [Cited by in F6Publishing: 117] [Article Influence: 19.3] [Reference Citation Analysis]
234 Bota DP, Van Nuffelen M, Zakariah AN, Vincent J. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. Journal of Laboratory and Clinical Medicine 2005;146:347-51. [DOI: 10.1016/j.lab.2005.08.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
235 Elefsiniotis I, Tsakiris SA, Barla G, Tasovasili A, Vrachatis D, Mavrogiannis C. Presepsin levels in cirrhotic patients with bacterial infections and/or portal hypertension-related bleeding, presenting with or without acute kidney injury. Ann Gastroenterol 2018;31:604-12. [PMID: 30174398 DOI: 10.20524/aog.2018.0292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
236 Lindvig KP, Teisner AS, Kjeldsen J, Strøm T, Toft P, Furhmann V, Krag A. Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice. World J Gastroenterol 2015; 21(29): 8964-8973 [PMID: 26269687 DOI: 10.3748/wjg.v21.i29.8964] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
237 Facciuto ME, Rochon C, Pandey M, Rodriguez-Davalos M, Samaniego S, Wolf DC, Kim-Schluger L, Rozenblit G, Sheiner PA. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009;11:398-404. [PMID: 19768144 DOI: 10.1111/j.1477-2574.2009.00073.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
238 Kim SH, Oh EG, Lee WH. Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey. Int J Nurs Stud. 2006;43:1047-1056. [PMID: 16952363 DOI: 10.1016/j.ijnurstu.2005.11.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
239 Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int. 2004;24:210-215. [PMID: 15189271 DOI: 10.1111/j.1478-3231.2004.00911.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
240 Inoue T, Kudo M, Maenishi O, Komuta M, Nakashima O, Kojiro M, Maekawa K. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:698-705. [PMID: 19234266 DOI: 10.2214/AJR.07.3282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
241 Xia F, Poon RT, Fan S, Wong J. Thoracoabdominal approach for right-sided hepatic resection for hepatocellular carcinoma. Journal of the American College of Surgeons 2003;196:418-27. [DOI: 10.1016/s1072-7515(02)01763-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
242 Basili S, Raparelli V, Napoleone L, Del Ben M, Merli M, Riggio O, Nocella C, Carnevale R, Pignatelli P, Violi F. Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis. Dig Liver Dis. 2014;46:632-638. [PMID: 24703705 DOI: 10.1016/j.dld.2014.02.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
243 Liu J, Li H, Xia J, Wang X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Liu J, Deng G, Zheng Y, Yan H, Qiao L, Xiang X, Zhang Q, Chen R, Chen J, Luo S, Gao, Ji L, Li J, Zhou X, Ren H, Lu S, Li S, Zhang W, Zheng X. Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis. Front Med (Lausanne) 2021;8:726950. [PMID: 34532334 DOI: 10.3389/fmed.2021.726950] [Reference Citation Analysis]
244 Stirpe F, Ravaioli M, Battelli MG, Musiani S, Grazi GL. Xanthine oxidoreductase activity in human liver disease. Am J Gastroenterology 2002;97:2079-85. [DOI: 10.1111/j.1572-0241.2002.05925.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
245 Hong WD, Dong LM, Jiang ZC, Zhu QH, Jin SQ. Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis. Clinics66:119-124. [PMID: 21437447 DOI: 10.1590/s1807-59322011000100021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
246 Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416-1423. [PMID: 29016470 DOI: 10.1097/meg.0000000000000986] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 16.3] [Reference Citation Analysis]
247 Ma Y, Chen F, Liu C, Xu Y, Wang M, Zhou T, Lei X, Feng P, Bai L, Tang H. A novel predictive score for citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation. Sci Rep 2020;10:12861. [PMID: 32732928 DOI: 10.1038/s41598-020-69902-2] [Reference Citation Analysis]
248 Bleszynski MS, Bressan AK, Joos E, Morad Hameed S, Ball CG. Acute care and emergency general surgery in patients with chronic liver disease: how can we optimize perioperative care? A review of the literature. World J Emerg Surg 2018;13:32. [PMID: 30034510 DOI: 10.1186/s13017-018-0194-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
249 Okamoto E, Amano Y, Fukuhara H, Furuta K, Miyake T, Sato S, Ishihara S, Kinoshita Y. Does gastroesophageal reflux have an influence on bleeding from esophageal varices? J Gastroenterol. 2008;43:803-808. [PMID: 18958550 DOI: 10.1007/s00535-008-2232-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
250 Lin HC, Yang YS, Teng CJ, Shen CH, Jan YG, Cheng SB, Wu CC, Lin YL, Huang CC, P'eng FK. Liver resection for hepatocellular carcinoma in patients with hematological malignancies. World J Surg Oncol 2017;15:194. [PMID: 29096656 DOI: 10.1186/s12957-017-1260-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
251 Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T; North American Study for the Treatment of Refractory Ascites Group. The North American Study for the Treatment of Refractory Ascites. Gastroenterology. 2003;124:634-641. [PMID: 12612902 DOI: 10.1053/gast.2003.50088] [Cited by in Crossref: 307] [Cited by in F6Publishing: 224] [Article Influence: 16.2] [Reference Citation Analysis]
252 Trojniak MP, Palozzo AC, Mazurek M, Jirillo A. Sorafenib in hepatocellular carcinoma - a post marketing evaluation. Immunopharmacol Immunotoxicol 2012;34:419-22. [PMID: 21981250 DOI: 10.3109/08923973.2011.617373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
253 Beyer G, Mahajan UM, Budde C, Bulla TJ, Kohlmann T, Kuhlmann L, Schütte K, Aghdassi AA, Weber E, Weiss FU, Drewes AM, Olesen SS, Lerch MM, Mayerle J. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology 2017;153:1544-1554.e2. [PMID: 28918191 DOI: 10.1053/j.gastro.2017.08.073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
254 Schaad HJ, Petty BG, Grasela DM, Christofalo B, Raymond R, Stewart M. Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment. Antimicrob Agents Chemother 1997;41:2793-6. [PMID: 9420063 DOI: 10.1128/AAC.41.12.2793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
255 Cheng YS, Pan S, Lien GS, Suk FM, Wu MS, Chen JN, Chen SH. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: a prospective, randomized long-term study. Gastrointest Endosc. 2001;53:566-571. [PMID: 11323580 DOI: 10.1067/mge.2001.114061] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
256 Sedrak H, Khalifa R, Elkafrawy A, Elewa H. Noninvasive predictors of large esophageal varices: is there an emerging role of aspartate aminotransferase-to-platelet ratio index in hepatocellular carcinoma? Egypt J Intern Med 2015;27:139-46. [DOI: 10.4103/1110-7782.174935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
257 Degre D, Bourgeois N, Boon N, Moine O, Louis H, Donckier V, Nakadi I, Closset J, Lingier P, Vereerstraeten P, Gelin M, Adler M. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transplant Int 2004;17:31-8. [DOI: 10.1111/j.1432-2277.2004.tb00380.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
258 Borzio M, Dionigi E, Rossini A, Marignani M, Sacco R, De Sio I, Bertolini E, Francica G, Giacomin A, Parisi G, Vicari S, Toldi A, Salmi A, Boccia S, Mitra M, Fornari F. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. Hepatology. 2018;67:2215-2225. [PMID: 29165831 DOI: 10.1002/hep.29662] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
259 Ye Y, Liu Z, Zhao M. CLIF-OF >9 predicts poor outcome in patients with Amanita phalloides poisoning. Am J Emerg Med 2021;39:96-101. [PMID: 31982218 DOI: 10.1016/j.ajem.2020.01.027] [Reference Citation Analysis]
260 Yang YY, Lin HC, Lee WC, Huang YT, Hou MC, Lee FY, Chang FY, Lee SD. Plasma erythropoieti. n level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function. J Gastroenterol Hepatol. 2003;18:1156-1161. [PMID: 12974902 DOI: 10.1046/j.1440-1746.2003.03144.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
261 Bekki Y, Marti J, Toshima T, Lewis S, Kamath A, Argiriadi P, Simpson W, Facciuto L, Patel RS, Gunasekaran G, Kim E, Schiano TD, Facciuto ME. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. Surgery 2021;169:1044-51. [PMID: 33648768 DOI: 10.1016/j.surg.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
262 Chandok N, Aljawad M, White A, Hernandez-Alejandro R, Marotta P, Yoshida EM. Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study. Can J Gastroenterol 2013;27:643-6. [PMID: 24040631 DOI: 10.1155/2013/897467] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
263 Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology. 1993;18:1061-1068. [PMID: 8225210 DOI: 10.1002/hep.1840180508] [Cited by in Crossref: 65] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
264 Panasiuk A, Zak J, Maciorkowska E, Panasiuk B, Prokopowicz D. Expression of β2-integrin on leukocytes in liver cirrhosis. World J Gastroenterol 2006; 12(38): 6193-6197 [PMID: 17036394 DOI: 10.3748/wjg.v12.i38.6193] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
265 Delhaye M, Moine O, Degraef C, Deviere J, Galand P. Prognostic value of hepatocyte proliferative activity after transjugular intrahepatic portosystemic shunt. Am J Gastroenterology 2001;96:1866-71. [DOI: 10.1111/j.1572-0241.2001.03885.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
266 Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, Wire MB. Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment. Antimicrob Agents Chemother 2009;53:5185-96. [PMID: 19667283 DOI: 10.1128/AAC.00632-09] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Riva A, Gray EH, Azarian S, Zamalloa A, McPhail MJW, Vincent RP, Williams R, Chokshi S, Patel VC, Edwards LA. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis. JHEP Rep 2020;2:100151. [PMID: 32838247 DOI: 10.1016/j.jhepr.2020.100151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
268 Dangleben DA, Jazaeri O, Wasser T, Cipolle M, Pasquale M. Impact of cirrhosis on outcomes in trauma. J Am Coll Surg. 2006;203:908-913. [PMID: 17116560 DOI: 10.1016/j.jamcollsurg.2006.08.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
269 Park SJ, Kim YK, Seo YS, Park SW, Lee HA, Kim TH, Suh SJ, Jung YK, Kim JH, An H, Yim HJ, Jang JY, Yeon JE, Byun KS. Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach. Clin Mol Hepatol 2016;22:487-94. [PMID: 28081588 DOI: 10.3350/cmh.2016.0050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
270 Lo G, Lin C, Lai K, Malik U, Ng W, Lee F, Lee S, Tsai Y, Lo K. Endoscopic injection sclerotherapy versus conservative treatment for patients with unresectable hepatocellular carcinoma and bleeding esophageal varices. Gastrointestinal Endoscopy 1991;37:161-4. [DOI: 10.1016/s0016-5107(91)70677-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
271 Hendren SK, Morris AM. Evaluating Patients Undergoing Colorectal Surgery to Estimate and Minimize Morbidity and Mortality. Surgical Clinics of North America 2013;93:1-20. [DOI: 10.1016/j.suc.2012.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
272 Sherman KE, Rouster SD, Mendenhall C, Thee D. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology 1999;30:265-70. [PMID: 10385665 DOI: 10.1002/hep.510300131] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
273 Zoli M, Iervese T, Merkel C, Bianchi G, Magalotti D, Marchesini G, Gatta A, Pisi E. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. Journal of Hepatology 1993;17:56-61. [DOI: 10.1016/s0168-8278(05)80521-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
274 Dong N, Chen WT, Bao M, Lu Y, Qian Y, Lu H. Self-Management Behaviors Among Patients With Liver Cirrhosis in Shanghai, China: A Cross-Sectional Study. Clin Nurs Res 2020;29:448-59. [PMID: 29806496 DOI: 10.1177/1054773818777914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
275 Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, Janssen HL. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338-343. [PMID: 11592594 DOI: 10.1016/s0168-8278(01)00131-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
276 Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44:53-61. [PMID: 16799972 DOI: 10.1002/hep.21231] [Cited by in Crossref: 355] [Cited by in F6Publishing: 280] [Article Influence: 22.2] [Reference Citation Analysis]
277 Chan SC, Fan ST, Lo CM, Liu CL. Effect of side and size of graft on surgical outcomes of adult-to-adult live donor liver transplantation. Liver Transpl. 2007;13:91-98. [PMID: 17192891 DOI: 10.1002/lt.20987] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
278 Wang R, Qi X, Guo X. Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis. Exp Ther Med 2017;14:5733-42. [PMID: 29285115 DOI: 10.3892/etm.2017.5321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
279 Small DS, Zhang W, Royalty J, Cannady EA, Downs D, Ortega D, Suico JG. Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib. Eur J Clin Pharmacol 2016;72:563-72. [PMID: 26857125 DOI: 10.1007/s00228-016-2017-1] [Reference Citation Analysis]
280 MacMathuna P, O'Connor MK, Weir DG, Keeling PW. Non-invasive diagnosis of portal vein occlusion by radionuclide angiography. Gut 1992;33:1671-4. [PMID: 1487169 DOI: 10.1136/gut.33.12.1671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
281 Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, Mizuno T, Iwabuchi S, Kunieda E. Threshold Doses for Focal Liver Reaction After Stereotactic Ablative Body Radiation Therapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging With Gd-EOB-DTPA. International Journal of Radiation Oncology*Biology*Physics 2014;88:306-11. [DOI: 10.1016/j.ijrobp.2013.10.045] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
282 Ishikawa T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J Gastroenterol 2012; 18(17): 2005-2008 [PMID: 22563186 DOI: 10.3748/wjg.v18.i17.2005] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
283 Dobbs NA, Twelves CJ. Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations? Br J Cancer 1998;77:1145-8. [PMID: 9569053 DOI: 10.1038/bjc.1998.190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
284 . Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002;30:1-6. [PMID: 11902249 DOI: 10.1097/00003246-200201000-00001] [Cited by in Crossref: 149] [Cited by in F6Publishing: 141] [Article Influence: 7.5] [Reference Citation Analysis]
285 Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746-753. [PMID: 14999693 DOI: 10.1002/hep.20126] [Cited by in Crossref: 274] [Cited by in F6Publishing: 204] [Article Influence: 15.2] [Reference Citation Analysis]
286 Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;240:102-107. [PMID: 15213625 DOI: 10.1097/01.sla.0000129672.51886.44] [Cited by in Crossref: 178] [Cited by in F6Publishing: 158] [Article Influence: 9.9] [Reference Citation Analysis]
287 Horn P, von Loeffelholz C, Forkert F, Stengel S, Reuken P, Aschenbach R, Stallmach A, Bruns T. Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis. Sci Rep 2018;8:9242. [PMID: 29915268 DOI: 10.1038/s41598-018-27543-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
288 Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, Lin CK. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000;32:461-465. [PMID: 10960435 DOI: 10.1053/jhep.2000.16236] [Cited by in Crossref: 199] [Cited by in F6Publishing: 139] [Article Influence: 9.0] [Reference Citation Analysis]
289 Elkerdawy MA, Ahmed MH, Zaghloul MS, Haseeb MT, Emara MH. Does gallbladder wall thickness measurement predict esophageal varices in cirrhotic patients with portal hypertension? Eur J Gastroenterol Hepatol 2021;33:917-25. [PMID: 33908388 DOI: 10.1097/MEG.0000000000002024] [Reference Citation Analysis]
290 Cantarini MC, Trevisani F, Morselli-Labate AM, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Am J Gastroenterol. 2006;101:91-98. [PMID: 16405539 DOI: 10.1111/j.1572-0241.2006.00364.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
291 Salinas-Botrán A, Sanz-Cánovas J, Pérez-Somarriba J, Pérez-Belmonte LM, Cobos-Palacios L, Rubio-Rivas M, de Cossío Tejido S, Manuel Ramos-Rincón J, Méndez-Bailón M, Gómez-Huelgas R; en nombre del grupo SEMI-COVID-19. [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain]. Rev Clin Esp 2021. [PMID: 34305156 DOI: 10.1016/j.rce.2021.06.004] [Reference Citation Analysis]
292 Baijal R, Amarapurkar D, Praveen Kumar HR, Kulkarni S, Shah N, Doshi S, Gupta D, Jain M, Patel N, Kamani P, Issar SK, Dharod M, Shah A, Chandnani M, Gautam S. A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver. Indian J Gastroenterol 2014;33:336-42. [DOI: 10.1007/s12664-014-0461-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
293 Bihari D, Westaby D, Gimson A, Crossley I, Harry J, Williams R. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension. Br J Clin Pharmacol 1984;17:753-7. [PMID: 6146330 DOI: 10.1111/j.1365-2125.1984.tb02413.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
294 Mathuna PM, Westaby D, Williams R. Taking the Tension out of the Portal System: An Approach to the Management of Portal Hypertension in the 1990s. Scandinavian Journal of Gastroenterology 2009;25:131-45. [DOI: 10.3109/00365529009093137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
295 Tribl GG, Trindade MC, Bittencourt T, Lorenzi-Filho G, Cardoso Alves R, Ciampi de Andrade D, Fonoff ET, Bor-Seng-Shu E, Machado AA, Schenck CH, Teixeira MJ, Barbosa ER. Wilson's disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med 2016;17:179-85. [PMID: 26763676 DOI: 10.1016/j.sleep.2015.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
296 Field KM, Michael M. Part II: Liver function in oncology: towards safer chemotherapy use. Lancet Oncol. 2008;9:1181-1190. [PMID: 19038765 DOI: 10.1016/s1470-2045(08)70307-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
297 Fang AP, Long JA, Zhang YJ, Liu ZY, Li QJ, Zhang DM, Luo Y, Zhong RH, Zhou ZG, Xu YJ, Xu XJ, Ling WH, Chen MS, Zhu HL. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival. Hepatology 2020;72:169-82. [PMID: 31677282 DOI: 10.1002/hep.31013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
298 Adams DH, Hughes M, Elliott TS. Microbial colonization of closed-system suction catheters used in liver transplant patients. Intensive Crit Care Nurs 1997;13:72-6. [PMID: 9180492 DOI: 10.1016/s0964-3397(97)80135-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
299 Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of Prognostic Importance in Primary Biliary Cirrhosis. Scandinavian Journal of Gastroenterology 2009;25:119-26. [DOI: 10.3109/00365529009107932] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
300 Putadechakum S, Klangjareonchai T, Soponsaritsuk A, Roongpisuthipong C. Nutritional status assessment in cirrhotic patients after protein supplementation. ISRN Gastroenterol. 2012;2012:690402. [PMID: 23304537 DOI: 10.5402/2012/690402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
301 Kinoshita A, Onoda H, Ueda K, Imai N, Iwaku A, Tanaka K, Fushiya N, Koike K, Nishino H, Tajiri H. Clinical characteristics and survival outcomes of super-elderly hepatocellular carcinoma patients not indicated for surgical resection. Hepatol Res 2016;46:E5-E14. [PMID: 25753133 DOI: 10.1111/hepr.12514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
302 Mann M, Kumar C, Zeng WF, Strauss MT. Artificial intelligence for proteomics and biomarker discovery. Cell Syst 2021;12:759-70. [PMID: 34411543 DOI: 10.1016/j.cels.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Esmaili J, Gholamrezanezhad A, Ebizadeh A. Correlation of liver-spleen scan findings with modified Child-Pugh classification. Rev Esp Med Nucl 2008;27:99-102. [PMID: 18367047 DOI: 10.1157/13117190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
304 Gaikwad NR, Gupta SJ, Samarth AR, Sankalecha TH. Handgrip dynamometry: a surrogate marker of malnutrition to predict the prognosis in alcoholic liver disease. Ann Gastroenterol. 2016;29:509-514. [PMID: 27708519 DOI: 10.20524/aog.2016.0049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
305 Li C, Peng Y, Mao B, Qian K. Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma. Oncotarget 2015;6:17792-804. [PMID: 25970775 DOI: 10.18632/oncotarget.3785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
306 Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, Florman S, Ward SC, Thung SN, Fiel M, Schiano TD. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation. 2015;99:151-157. [PMID: 25029385 DOI: 10.1097/tp.0000000000000286] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
307 Im GY, Lubezky N, Facciuto ME, Schiano TD. Surgery in Patients with Portal Hypertension. Clinics in Liver Disease 2014;18:477-505. [DOI: 10.1016/j.cld.2014.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
308 Körner T, Kropf J, Gressner AM. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol. 1996;25:684-688. [PMID: 8938546 DOI: 10.1016/s0168-8278(96)80239-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
309 Bertoni G, Sassatelli R, Fornaciari G, Briglia R, Tansini P, Grisendi A, Pedretti G, Beltrami M, Conigliaro R, Pacchione D, Bedogni G. Oral Isosorbide-5-Mononitrate Reduces the Rebleeding Rate during the Course of Injection Sclerotherapy for Esophageal Varices. Scandinavian Journal of Gastroenterology 2009;29:363-70. [DOI: 10.3109/00365529409094851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
310 Tanaka H, Kubo S, Tsukamoto T, Shuto T, Takemura S, Yamamoto T, Okuda T, Kanazawa A, Hirohashi K. Recurrence Rate and Transplantability After Liver Resection in Patients With Hepatocellular Carcinoma Who Initially Met Transplantation Criteria. Transplantation Proceedings 2005;37:1254-6. [DOI: 10.1016/j.transproceed.2004.11.044] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
311 Kawamura-Yasui N, Kaito M, Nakagawa N, Fujita N, Ikoma J, Gabazza EC, Watanabe S, Adachi Y. Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease. J Clin Lab Anal. 1999;13:31-34. [PMID: 10025735 DOI: 10.1002/(SICI)1098-2825(1999)13: 1<31: : AID-JCLA6>3.0.CO; 2-Y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
312 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 5.0] [Reference Citation Analysis]
313 Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy. Liver Transpl. 2003;9:684-692. [PMID: 12827553 DOI: 10.1053/jlts.2003.50147] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 10.2] [Reference Citation Analysis]
314 Okugawa H, Maruyama H, Kobayashi S, Yoshizumi H, Matsutani S, Yokosuka O. Therapeutic effect of balloon-occluded retrograde transvenous obliteration for gastric varices in relation to haemodynamics in the short gastric vein. Br J Radiol 2009;82:930-5. [PMID: 19470572 DOI: 10.1259/bjr/28956799] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
315 Shiozawa K, Watanabe M, Ikehara T, Kogame M, Kikuchi Y, Igarashi Y, Sumino Y. Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result. Oncol Lett. 2016;12:579-584. [PMID: 27347183 DOI: 10.3892/ol.2016.4669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
316 Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices. Lancet 1982;2:66-8. [PMID: 6123808 DOI: 10.1016/s0140-6736(82)91689-0] [Cited by in Crossref: 125] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
317 Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Vasilieva L, Archimandritis AJ. Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol 2006; 12(25): 4020-4025 [PMID: 16810751 DOI: 10.3748/wjg.v12.i25.4020] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
318 Rijken DC, Kock EL, Guimarães AH, Talens S, Darwish Murad S, Janssen HL, Leebeek FW. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J Thromb Haemost 2012;10:2116-22. [PMID: 22906184 DOI: 10.1111/j.1538-7836.2012.04901.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
319 Macmathuna P, Vlavianos P, Wendon J, Gove CD, Westaby D, Williams R. Metabolic effects of β-adrenergic receptor blockade in advanced alcoholic cirrhosis. Journal of Hepatology 1993;17:74-80. [DOI: 10.1016/s0168-8278(05)80524-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
320 Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology. 2002;36:410-417. [PMID: 12143050 DOI: 10.1053/jhep.2002.34744] [Cited by in Crossref: 122] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
321 Mota A, Guedes F, Areias J, Pinho L, Cardoso MF. Alcohol consumption among patients with hepatitis B infection in northern Portugal considering gender and hepatitis B virus genotype differences. Alcohol. 2010;44:149-156. [PMID: 20116194 DOI: 10.1016/j.alcohol.2009.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
322 Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. On the origin and the consequences of circadian abnormalities in patients with cirrhosis. Am J Gastroenterol 2010;105:1773-81. [PMID: 20332771 DOI: 10.1038/ajg.2010.86] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
323 Horibe M, Kaneko T, Yokogawa N, Yokota T, Okawa O, Nakatani Y, Ogura Y, Matsuzaki J, Iwasaki E, Hosoe N, Masaoka T, Inadomi JM, Suzuki H, Kanai T, Namiki S. A simple scoring system to assess the need for an endoscopic intervention in suspected upper gastrointestinal bleeding: A prospective cohort study. Digestive and Liver Disease 2016;48:1180-6. [DOI: 10.1016/j.dld.2016.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
324 Franchis RD, Massimo P, Felice C. Endoscopic Diagnosis and Classification of Varices. Gastrointestinal Endoscopy Clinics of North America 1992;2:17-30. [DOI: 10.1016/s1052-5157(18)30654-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
325 Wind S, Schmid U, Freiwald M, Marzin K, Lotz R, Ebner T, Stopfer P, Dallinger C. Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. Clin Pharmacokinet 2019;58:1131-47. [PMID: 31016670 DOI: 10.1007/s40262-019-00766-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
326 Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, D'amico F, Ciarleglio FA, Boccagni P, Brolese A, Zanus G, D'amico DF. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? Journal of Hepatology 2004;40:124-31. [DOI: 10.1016/j.jhep.2003.09.027] [Cited by in Crossref: 133] [Cited by in F6Publishing: 122] [Article Influence: 7.4] [Reference Citation Analysis]
327 LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995;108:1143-1151. [PMID: 7698582 DOI: 10.1016/0016-5085(95)90213-9] [Cited by in Crossref: 229] [Cited by in F6Publishing: 196] [Article Influence: 8.5] [Reference Citation Analysis]
328 Shinoda M, Wakabayashi G, Shimazu M, Saito H, Hoshino K, Tanabe M, Morikawa Y, Endo S, Ishii H, Kitajima M. Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure. J Gastroenterol Hepatol. 2006;21:1731-1736. [PMID: 16984598 DOI: 10.1111/j.1440-1746.2006.04376.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
329 D'Amico G, Malizia G, D'Amico M. Prognosis research and risk of bias. Intern Emerg Med 2016;11:251-60. [PMID: 26910239 DOI: 10.1007/s11739-016-1404-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
330 Chirapongsathorn S, Manatsathit W, Farrell A, Suksamai A. Safety and efficacy of endoscopic cyanoacrylate injection in the management of gastric varices: A systematic review and meta-analysis. JGH Open 2021;5:1047-55. [PMID: 34584974 DOI: 10.1002/jgh3.12629] [Reference Citation Analysis]
331 Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, Huang HC, Chiang HT. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology 1998;28:391-5. [PMID: 9696002 DOI: 10.1002/hep.510280215] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
332 Miotto N, Mendes LC, Zanaga LP, Lazarini MSK, Goncales ESL, Pedro MN, Goncales FL Jr, Stucchi RSB, Vigani AG. All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response. PLoS One 2018;13:e0199941. [PMID: 29990371 DOI: 10.1371/journal.pone.0199941] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
333 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
334 Hanazaki K, Ichikawa K, Munekage M, Kitagawa H, Dabanaka K, Namikawa T. Effect of Daikenchuto (TJ-100) on abdominal bloating in hepatectomized patients. World J Gastrointest Surg 2013; 5(4): 115-122 [PMID: 23671738 DOI: 10.4240/wjgs.v5.i4.115] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
335 Ariza J, Xiol X, Esteve M, Bañeres FF, Liñares J, Alonso T, Gudiol F. Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology 1991;14:91-8. [DOI: 10.1002/hep.1840140115] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
336 Chiappa A, Zbar A, Audisio R, Leone B, Biella F, Staudacher C. Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2000;26:387-92. [DOI: 10.1053/ejso.1999.0904] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
337 van den Berg EH, Douwes RM, de Meijer VE, Schreuder TCMA, Blokzijl H. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity. Dig Liver Dis. 2018;50:68-75. [PMID: 28935188 DOI: 10.1016/j.dld.2017.08.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
338 Kim SY, Wu EH, Park SH, Wang ZJ, Hope TA, Yee J, Zhao LQ, Chang WC, Yeh BM. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent. Abdom Radiol (NY) 2016;41:1522-31. [PMID: 26971341 DOI: 10.1007/s00261-016-0703-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
339 Fujiwara N, Tateishi R, Akahane M, Taguri M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Ohtomo K, Koike K. Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma. PLoS One 2013;8:e76018. [PMID: 24098420 DOI: 10.1371/journal.pone.0076018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
340 Tietge UJ, Bahr MJ, Manns MP, Böker KH. Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation. Transplantation. 2003;75:804-810. [PMID: 12660506 DOI: 10.1097/01.tp.0000054843.68371.aa] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
341 Santolaria F, González-Reimers E, Pérez-Manzano JL, Milena A, Gómez-Rodríguez MA, González-Díaz A, de la Vega MJ, Martínez-Riera A. Osteopenia assessed by body composition analysis is related to malnutrition in alcoholic patients. Alcohol. 2000;22:147-157. [PMID: 11163122 DOI: 10.1016/s0741-8329(00)00115-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
342 Kalafateli M, Konstantakis C, Thomopoulos K, Triantos C. Impact of muscle wasting on survival in patients with liver cirrhosis. World J Gastroenterol 2015; 21(24): 7357-7361 [PMID: 26139982 DOI: 10.3748/wjg.v21.i24.7357] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
343 Ormarsdóttir S, Ljunggren O, Mallmin H, Brahm H, Lööf L. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol. 1999;31:84-90. [PMID: 10424287 DOI: 10.1016/S0168-8278(99)80167-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
344 Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 2001;121:389-95. [PMID: 11487548 DOI: 10.1053/gast.2001.26295] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 4.8] [Reference Citation Analysis]
345 Buchanan R, Sinclair JMA. Alcohol use disorder and the liver. Addiction 2021;116:1270-8. [PMID: 32710592 DOI: 10.1111/add.15204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
346 Furuya KN, Durie PR, Roberts EA, Soldin SJ, Verjee Z, Yung-jato L, Giesbrecht E, Ellis L. Glycine conjugation of para-aminobenzoic acid (PABA): A quantitative test of liver function. Clinical Biochemistry 1995;28:531-40. [DOI: 10.1016/0009-9120(95)00040-g] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
347 Tas A, Akbal E, Beyazit Y, Kocak E. Serum lactate level predict mortality in elderly patients with cirrhosis. Wien Klin Wochenschr. 2012;124:520-525. [PMID: 22810366 DOI: 10.1007/s00508-012-0208-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
348 Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995;169:28-34; discussion 34-35. [PMID: 7817995 DOI: 10.1016/s0002-9610(99)80106-8] [Cited by in Crossref: 219] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
349 Thomson AW, Satoh S, Nüssler AK, Tamura K, Woo J, Gavaler J, van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol. 1994;95:83-90. [PMID: 7904546 DOI: 10.1111/j.1365-2249.1994.tb06019.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 1.4] [Reference Citation Analysis]
350 Saito M, Seo Y, Yano Y, Momose K, Hirano H, Yoshida M, Azuma T. Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment. PLoS One 2013;8:e55441. [PMID: 23520445 DOI: 10.1371/journal.pone.0055441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
351 Colagrande S, Regini F, Taliani GG, Nardi C, Inghilesi AL. Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up. World J Hepatol 2015; 7(8): 1041-1053 [PMID: 26052393 DOI: 10.4254/wjh.v7.i8.1041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
352 Khong PL, Ooi CG, Saing H, Chan KL, Wong WH, Tam PK, Han H, Peh WC. Portal venous velocity in the follow-up of patients with biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2002;37:873-6. [PMID: 12037753 DOI: 10.1053/jpsu.2002.32892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
353 Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J Surg. 2008;32:2223-2229. [PMID: 18642042 DOI: 10.1007/s00268-008-9688-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
354 Steele JD, Dillon JF, Plevris JN, Hauer JL, Bouchier IA, Hayes PC. Hand skin temperature changes in patients with chronic liver disease. Journal of Hepatology 1994;21:927-33. [DOI: 10.1016/s0168-8278(05)80597-5] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
355 Trevisani F, Bernardi M, Arienti V, Scrivano P, Mazziotti A, Cavallari A, Patrono D, Piazzi S, Gozzetti G, Gasbarrini G. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis. Hepatology 1994;19:329-38. [DOI: 10.1002/hep.1840190210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
356 Petzke KJ, Feist T, Fleig WE, Metges CC. Nitrogen isotopic composition in hair protein is different in liver cirrhotic patients. Rapid Commun Mass Spectrom 2006;20:2973-8. [PMID: 16955536 DOI: 10.1002/rcm.2695] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
357 Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. The Lancet 2002;359:1734-9. [DOI: 10.1016/s0140-6736(02)08649-x] [Cited by in Crossref: 2274] [Cited by in F6Publishing: 844] [Article Influence: 113.7] [Reference Citation Analysis]
358 Saleh ZM, Solano QP, Louissaint J, Jepsen P, Tapper EB. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis. United European Gastroenterol J 2021;9:672-80. [PMID: 34102040 DOI: 10.1002/ueg2.12104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
359 Elsewify WAE, Hassan EA, Mekky MA, Abd El-Rehim ASE, Sayed ZEA, Abdel Malek MO, ElMelegy TTH, Sabry A. Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels. Int J Gen Med 2020;13:147-55. [PMID: 32431531 DOI: 10.2147/IJGM.S249272] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
360 Wright AS, Rikkers LF. Current management of portal hypertension. J Gastrointest Surg. 2005;9:992-1005. [PMID: 16137597 DOI: 10.1016/j.gassur.2004.09.028] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
361 Donadon M, Fontana A, Procopio F, Del Fabbro D, Cimino M, Viganò L, Palmisano A, Torzilli G. Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy? Updates Surg 2019;71:57-66. [DOI: 10.1007/s13304-019-00626-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
362 Maegawa FB, Shehorn L, Aziz H, Kettelle J, Jie T, Riall TS. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma. JAMA Netw Open 2019;2:e187142. [PMID: 30657533 DOI: 10.1001/jamanetworkopen.2018.7142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
363 Jalan R, Stadlbauer V, Sen S, Cheshire L, Chang YM, Mookerjee RP. Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care. 2012;16:R227. [PMID: 23186071 DOI: 10.1186/cc11882] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
364 Rodrigue JR, Hanto DW, Curry MP. Patients' expectations and success criteria for liver transplantation: Patients' Transplant Success Criteria. Liver Transpl 2011;17:1309-17. [DOI: 10.1002/lt.22355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
365 Lee W, Lin H, Yang Y, Hou M, Lee F, Chang F, Lee S. Hemodynamic Effects of A Combination of Prazosin and Terlipressin in Patients With Viral Cirrhosis: . American Journal of Gastroenterology 2001;96:1210-6. [DOI: 10.1111/j.1572-0241.2001.03705.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
366 Zochodne DW. Neuropathies Associated with Renal Failure, Hepatic Disorders, Chronic Respiratory Disease, and Critical Illness. Peripheral Neuropathy. Elsevier; 2005. pp. 2017-37. [DOI: 10.1016/b978-0-7216-9491-7.50090-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
367 Yang S, Wu K, Wang J, Lee C, Kuo Y, Tai W, Chen C, Chiou S, Lu S, Hu T, Changchien C, Chuah S. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions. Hepatol Int 2013;7:257-67. [DOI: 10.1007/s12072-012-9378-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
368 Riggio O, Angeloni S, Ciuffa L, Nicolini G, Attili A, Albanese C, Merli M. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clinical Nutrition 2003;22:553-9. [DOI: 10.1016/s0261-5614(03)00058-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
369 Jaroszewicz J, Rogalska M, Flisiak R. Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis. Biomarkers 2008;13:478-85. [DOI: 10.1080/13547500802033391] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
370 Tsai JF, Chuang LY, Jeng JE, Yang ML, Chang WY, Hsieh MY, Lin ZY, Tsai JH. Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma. Medicine (Baltimore). 1997;76:213-226. [PMID: 9193456 DOI: 10.1097/00005792-199705000-00007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
371 Bernabeu-wittel M, Barón-franco B, Murcia-zaragoza J, Fuertes-martín A, Ramos-cantos C, Fernández-moyano A, Galindo F, Ollero-baturone M. A multi-institutional, hospital-based assessment of clinical, functional, sociofamilial and health-care characteristics of polypathological patients (PP). Archives of Gerontology and Geriatrics 2011;53:284-91. [DOI: 10.1016/j.archger.2010.12.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
372 Beebe SJ. Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields. J Hepatocell Carcinoma 2015;2:49-55. [PMID: 27508194 DOI: 10.2147/JHC.S83941] [Reference Citation Analysis]
373 Levesque E, Hoti E, Azoulay D, Ichaï P, Habouchi H, Castaing D, Samuel D, Saliba F. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012;56:95-102. [PMID: 21835136 DOI: 10.1016/j.jhep.2011.06.024] [Cited by in Crossref: 116] [Cited by in F6Publishing: 99] [Article Influence: 10.5] [Reference Citation Analysis]
374 Chen G, Nomikos GG, Affinito J, Jacobson W, Zhao Z, Wang S, Xie J. Effects of Intrinsic Factors on the Clinical Pharmacokinetics of Vortioxetine. Clinical Pharmacology in Drug Development 2018;7:880-8. [DOI: 10.1002/cpdd.577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
375 Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Dose adjustment in patients with liver disease. Drug Saf 2005;28:529-45. [PMID: 15924505 DOI: 10.2165/00002018-200528060-00005] [Cited by in Crossref: 144] [Cited by in F6Publishing: 103] [Article Influence: 9.0] [Reference Citation Analysis]
376 Umehara M, Onda M, Tajiri T, Toba M, Yoshida H, Yamashita K. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study. Gastrointest Endosc. 1999;50:7-12. [PMID: 10385714 DOI: 10.1016/s0016-5107(99)70336-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
377 Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y, Yao C, Jia W, Liu P. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. J Proteome Res 2016;15:1126-34. [PMID: 25964117 DOI: 10.1021/acs.jproteome.5b00217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
378 Yu T, Han C, Zhu G, Liao X, Qin W, Yang C, Liu Z, Su H, Liu X, Yu L, Liu Z, Lu S, Chen Z, Liang Y, Huang J, Qin X, Gui Y, Li J, Peng T. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Med 2017;6:1587-600. [PMID: 28568708 DOI: 10.1002/cam4.1077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
379 Shindoh J, Kawamura Y, Kobayashi Y, Kiya Y, Sugawara T, Akuta N, Kobayashi M, Suzuki Y, Ikeda K, Hashimoto M. Platelet-Albumin Score as a Sensitive Measure for Surgical Risk Prediction and Survival Outcomes of Patients with Hepatocellular Carcinoma. J Gastrointest Surg 2019;23:76-83. [DOI: 10.1007/s11605-018-3871-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
380 Fujitani K, Kurokawa Y, Takeno A, Kawabata R, Omori T, Imamura H, Hirao M, Endo S, Kawada J, Moon JH, Kobayashi N, Takahashi T, Yamasaki M, Takiguchi S, Mori M, Eguchi H, Doki Y; Osaka University Clinical Research Group for Gastroenterological Surgery. Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality. Ann Surg Oncol 2021. [PMID: 34480277 DOI: 10.1245/s10434-021-10750-3] [Reference Citation Analysis]
381 Shiomi S, Iwata Y, Sasaki N, Morikawa H, Tamori A, Habu D, Takeda T, Nishiguchi S, Kuroki T, Ochi H. Assessment of hepatic blood flow by PET with 15O water: Correlation between per-rectal portal scintigraphy with 99Tcm-pertechnetate and scintigraphy with 99Tcm-GSA: . Nuclear Medicine Communications 2000;21:533-8. [DOI: 10.1097/00006231-200006000-00006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
382 Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61 [PMID: 22966483 DOI: 10.4292/wjgpt.v3.i4.49] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
383 Riggio O, Mannaioni G, Ridola L, Angeloni S, Merli M, Carlà V, Salvatori FM, Moroni F. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy. Am J Gastroenterol. 2010;105:1374-1381. [PMID: 20125128 DOI: 10.1038/ajg.2009.738] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
384 Takamoto T, Sugawara Y, Hashimoto T, Makuuchi M. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2016;10:341-57. [PMID: 26558422 DOI: 10.1586/17474124.2016.1116381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
385 Söderlund C. Denver Peritoneovenous Shunting for Malignant or Cirrhotic Ascites: A Prospective Consecutive Series. Scandinavian Journal of Gastroenterology 2009;21:1161-72. [DOI: 10.3109/00365528608996438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
386 Moreau R, Hadengue A, Soupison T, Mamzer M, Kirstetter P, Saraux J, Assous M, Roche-sicot J, Sicot C. Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. Liver 1993;13:20-4. [DOI: 10.1111/j.1600-0676.1993.tb00600.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
387 Venkatakrishnan K, Liu Y, Noe D, Mertz J, Bargfrede M, Marbury T, Farbakhsh K, Oliva C, Milton A. Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment. Br J Clin Pharmacol 2014;77:998-1010. [PMID: 24134216 DOI: 10.1111/bcp.12261] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
388 Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf K, Albrecht T. Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA. American Journal of Roentgenology 2009;193:1053-60. [DOI: 10.2214/ajr.08.1946] [Cited by in Crossref: 120] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
389 Vaz J, Strömberg U, Eriksson B, Buchebner D, Midlöv P. Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden. BMC Public Health 2020;20:1820. [PMID: 33256682 DOI: 10.1186/s12889-020-09783-2] [Reference Citation Analysis]
390 Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005;11:1117-1126. [PMID: 16123960 DOI: 10.1002/lt.20469] [Cited by in Crossref: 136] [Cited by in F6Publishing: 128] [Article Influence: 8.0] [Reference Citation Analysis]
391 Bolognesi M, Sacerdoti D, Bombonato G, Angeli P, Gerunda G, Merenda R, Volpin R, Iemmolo R, Gatta A. Splenic impedance indices: A useful method to monitor patients after liver transplantation? Hepatology 1998;27:674-8. [DOI: 10.1002/hep.510270306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
392 Kim YK, Kim CS, Han YM, Kwak HS, Jin GY, Hwang SB, Chung GH, Lee SY, Yu HC. Detection of Hepatocellular Carcinoma: Gadoxetic Acid-Enhanced 3-Dimensional Magnetic Resonance Imaging Versus Multi-Detector Row Computed Tomography. Journal of Computer Assisted Tomography 2009;33:844-50. [DOI: 10.1097/rct.0b013e3181a7e3c7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
393 Bhasin DK, Zargar SA, Mandal M, Goenka M, Singh R. Endoscopic removal of impacted Sengstaken-Blakemore tube. Surg Endosc 1989;3:54-5. [PMID: 2785295 DOI: 10.1007/BF00591318] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
394 Papatheodoridis GV, Cholongitas E, Dimitriadou E, Touloumi G, Sevastianos V, Archimandritis AJ. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005; 11(20): 3099-3104 [PMID: 15918197 DOI: 10.3748/wjg.v11.i20.3099] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
395 Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999;30:890-895. [PMID: 10365817 DOI: 10.1016/s0168-8278(99)80144-5] [Cited by in Crossref: 364] [Cited by in F6Publishing: 111] [Article Influence: 15.8] [Reference Citation Analysis]
396 Knox JJ. Addressing the Interplay of Liver Disease and Hepatocellular Carcinoma on Patient Survival: The ALBI Scoring Model. JCO 2015;33:529-31. [DOI: 10.1200/jco.2014.59.0521] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
397 Shangraw RE, Jahoor F. Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis. Metabolism 2004;53:1087-94. [DOI: 10.1016/j.metabol.2004.02.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
398 Kobayashi T, Kubota K, Imamura H, Hasegawa K, Inoue Y, Takayama T, Makuuchi M. Hepatic phenylalanine metabolism measured by the [13C]phenylalanine breath test. Eur J Clin Invest. 2001;31:356-361. [PMID: 11298784 DOI: 10.1046/j.1365-2362.2001.00803.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
399 Benndorf G, Lehmann TN. Bilateral diploic arteriovenous fistula causing scalp hematoma: Case report. Journal of Neurosurgery 2004;100:950-5. [DOI: 10.3171/jns.2004.100.5.0950] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
400 Rodrigues AT, Liu PM, Fagundes ED, Queiroz TC, de Souza Haueisen Barbosa P, Silva SL, Simões e Silva AC, Miranda DM, Ferreira AR, Alberti LR. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome. Journal of Pediatric Gastroenterology & Nutrition 2016;63:76-81. [DOI: 10.1097/mpg.0000000000001125] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
401 Cárdenes HR, Lasley F. Primary Liver Cancer. In: Lo SS, Teh BS, Lu JJ, Schefter TE, editors. Stereotactic Body Radiation Therapy. Berlin: Springer Berlin Heidelberg; 2012. pp. 163-82. [DOI: 10.1007/174_2012_548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
402 Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, Crawford DH. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology. 2000;32:1200-1207. [PMID: 11093725 DOI: 10.1053/jhep.2000.20348] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
403 Li S, Wang Q, Mei J, Wang J, Zhong XP, Ling Y, Guo Z, Lu LH, Wei W, Guo R. Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases. J Cancer 2019;10:5007-14. [PMID: 31598173 DOI: 10.7150/jca.35355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
404 Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002; 8(2): 237-242 [PMID: 11925599 DOI: 10.3748/wjg.v8.i2.237] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
405 Urita Y, Kondo E, Muto M, Yamada S, Hachiya A, Ishihara M, Ozaki M, Nishino M, Naruki Y, Otsuka S. Combined endoscopic clipping and injection sclerotherapy for esophageal varices. Gastrointestinal Endoscopy 1996;43:140-3. [DOI: 10.1016/s0016-5107(06)80117-3] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
406 Abdelaal UM, Morita E, Nouda S, Kuramoto T, Miyaji K, Fukui H, Tsuda Y, Fukuda A, Murano M, Tokioka S. Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact? J Clin Biochem Nutr. 2010;47:37-44. [PMID: 20664729 DOI: 10.3164/jcbn.10-14] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
407 Aljiffry M, Walsh M, Peltekian K, Molinari M. Type II Gall Bladder Perforation with Abdominal Wall Abscess in a Cirrhotic Patient: Case Report and Review of the Literature. Journal of Surgical Education 2008;65:367-71. [DOI: 10.1016/j.jsurg.2008.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
408 Lugo G, Castañeda-Hernández G. Amikacin Bayesian forecasting in critically ill patients with sepsis and cirrhosis. Ther Drug Monit 1997;19:271-6. [PMID: 9200766 DOI: 10.1097/00007691-199706000-00005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
409 Diniz PHC, Silva SDDC, Faria LC, Vidigal PVT, Ferrari TCA. Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment. Clinics (Sao Paulo) 2020;75:e1529. [PMID: 32520221 DOI: 10.6061/clinics/2020/e1529] [Reference Citation Analysis]
410 Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 1991;101:1382-90. [PMID: 1718809 DOI: 10.1016/0016-5085(91)90092-y] [Cited by in Crossref: 84] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
411 Hidaka M, Eguchi S. Budd-Chiari syndrome: Focus on surgical treatment. Hepatol Res 2017;47:142-8. [PMID: 27249222 DOI: 10.1111/hepr.12752] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
412 Ferreira CPDC, Ribeiro MA, Szutan LA. Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib. Rev Assoc Med Bras (1992) 2020;66:275-83. [PMID: 32520145 DOI: 10.1590/1806-9282.66.3.275] [Reference Citation Analysis]
413 Goshima S, Kanematsu M, Noda Y, Kondo H, Watanabe H, Bae KT. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma. AJR Am J Roentgenol. 2015;204:W543-W549. [PMID: 25905960 DOI: 10.2214/ajr.14.13235] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 8.1] [Reference Citation Analysis]
414 Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, Rautou PE, Albuquerque M, Picq O, Gupta AC, Ferrere G, Gilgenkrantz H, Kiaf B, Toubal A, Beaudoin L, Lettéron P, Moreau R, Lehuen A, Lotersztajn S. Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nat Commun 2018;9:2146. [PMID: 29858567 DOI: 10.1038/s41467-018-04450-y] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 18.0] [Reference Citation Analysis]
415 Numata K, Tanaka K, Kiba T, Mitsui K, Saito S, Sekihara H. Hemodynamic changes in hepatic artery after glucose ingestion in healthy subjects and patients with cirrhosis. J Clin Ultrasound 1998;26:137-42. [DOI: 10.1002/(sici)1097-0096(199803/04)26:3<137::aid-jcu5>3.0.co;2-n] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
416 Romero S, Martín C, Hernandez L, Verdu J, Trigo C, Perez-Mateo M, Alemany L. Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest. 1998;114:154-159. [PMID: 9674463 DOI: 10.1378/chest.114.1.154] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
417 Bernsmeier C, Cavazza A, Fatourou EM, Theocharidou E, Akintimehin A, Baumgartner B, Dhar A, Auzinger G, Thursz M, Bernal W, Wendon JA, Karvellas CJ, Antoniades CG, McPhail MJW. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Aliment Pharmacol Ther 2020;52:855-65. [PMID: 32683724 DOI: 10.1111/apt.15932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
418 Zhang Y, Wang C, Li H, Ding Y. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Medicine (Baltimore) 2019;98:e13929. [PMID: 30653099 DOI: 10.1097/MD.0000000000013929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
419 D’amico G. Esophageal varices: from appearance to rupture; natural history and prognostic indicators. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 147-54. [DOI: 10.1007/978-94-007-1042-9_17] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
420 Pateria P, de Boer B, MacQuillan G. Liver abnormalities in drug and substance abusers. Best Pract Res Clin Gastroenterol. 2013;27:577-596. [PMID: 24090944 DOI: 10.1016/j.bpg.2013.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
421 Ahmad YK, Tawfeek S, Sharaf-eldin M, Elbatea HE, Kobtan A, El-kalla F, Badawi R, Abd-elsalam S. Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients. Hosp Pharm 2017;52:294-301. [DOI: 10.1310/hpx5204-294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
422 Westaby D, Hayes PC, Gimson AE, Polson RJ, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology. 1989;9:274-277. [PMID: 2492252 DOI: 10.1002/hep.1840090219] [Cited by in Crossref: 157] [Cited by in F6Publishing: 118] [Article Influence: 4.8] [Reference Citation Analysis]
423 Di Maio M, Daniele B, Perrone F. Role of sorafenib in HCC patients with compromised liver function. Nat Rev Clin Oncol 2009;6:505-6. [DOI: 10.1038/nrclinonc.2009.114] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
424 Williams BR, Nazarians A, Gill MA. A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther 2003;25:1634-53. [PMID: 12860489 DOI: 10.1016/s0149-2918(03)80160-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
425 Wang XH, Jiang XM, Gao PX, Liu Q, Yuan JH, Chen SJ. Risk factors and prognostic analysis of acute-on-chronic liver failure of chronic hepatitis B after cessation of nucleos(t)ide analogs. Eur J Gastroenterol Hepatol 2020;32:265-75. [PMID: 31789948 DOI: 10.1097/MEG.0000000000001574] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Lombardo L, Rota Scalabrini D, Vineis P, De La Pierre M. Malignant lymphoproliferative disorders in liver cirrhosis. Ann Oncol. 1993;4:245-250. [PMID: 8471557 DOI: 10.1093/oxfordjournals.annonc.a058465] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
427 Ohki T, Sato K, Kondo M, Goto E, Sato T, Kondo Y, Akamatsu M, Sato S, Yoshida H, Koike Y, Obi S. Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Drugs Real World Outcomes 2020;7:141-9. [PMID: 32048238 DOI: 10.1007/s40801-020-00179-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
428 Ferreira PP, Camara EJN, Paula RLPD, Zollinger CC, Cavalcanti AR, Bittencourt PL. Prevalence of hepatopulmonary syndrome in patients with decompensated chronic liver disease and its impact on short-term survival. Arq Gastroenterol 2008;45:34-7. [DOI: 10.1590/s0004-28032008000100007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
429 Yassin YM, Sherif SM. Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices—an interim report. British Journal of Surgery 1983;70:20-2. [DOI: 10.1002/bjs.1800700107] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
430 Nishida T, Kobashi H, Fujioka S, Fujio K, Takaguchi K, Ikeda H, Kawaguchi M, Ando M, Araki Y, Higashi T. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis. J Gastroenterol Hepatol. 2008;23:794-803. [PMID: 18086120 DOI: 10.1111/j.1440-1746.2007.05240.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
431 Reuben A. Child comes of age. Hepatology. 2002;35:244-245. [PMID: 11786987 DOI: 10.1053/jhep.2002.0350244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
432 García Ruiz P, Canora Lebrato J, Díez Ruiz A, Fuchs D, Wachter H. [Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis]. Med Clin (Barc) 2004;122:441-3. [PMID: 15104953 DOI: 10.1016/s0025-7753(04)74267-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
433 Shangraw RE, Robinson ST. Oxygen metabolism during liver transplantation: the effect of dichloroacetate. Anesth Analg 1997;85:746-52. [PMID: 9322450 DOI: 10.1097/00000539-199710000-00007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
434 Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 1996;24:377-384. [PMID: 8738722 DOI: 10.1016/s0168-8278(96)80156-5] [Cited by in Crossref: 91] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
435 Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore) 2017;96:e7142. [PMID: 28614241 DOI: 10.1097/MD.0000000000007142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
436 Bragagnolo Jr. MA, Teodoro V, Lucchesi LM, Ribeiro TCDR, Tufik S, Kondo M. Detecção de encefalopatia hepática mínima através de testes neuropsicológicos e neurofisiológicos e o papel da amônia no seu diagnóstico. Arq Gastroenterol 2009;46:43-9. [DOI: 10.1590/s0004-28032009000100013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
437 Khalifa A, Rockey DC. Lower Gastrointestinal Bleeding in Patients With Cirrhosis-Etiology and Outcomes. Am J Med Sci 2020;359:206-11. [PMID: 32087941 DOI: 10.1016/j.amjms.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
438 Fimognari FL, De Santis A, Piccheri C, Moscatelli R, Gigliotti F, Vestri A, Attili A, Violi F. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med. 2005;146:238-243. [PMID: 16194685 DOI: 10.1016/j.lab.2005.06.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
439 Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193-199. [PMID: 25441595 DOI: 10.1016/j.nut.2014.07.005] [Cited by in Crossref: 201] [Cited by in F6Publishing: 181] [Article Influence: 25.1] [Reference Citation Analysis]
440 A European Multicentre Study Group. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. Journal of Hepatology 1993;17:227-35. [DOI: 10.1016/s0168-8278(05)80043-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
441 Qi R, Zhang L, Wu S, Zhong J, Zhang Z, Zhong Y, Ni L, Zhang Z, Li K, Jiao Q. Altered resting-state brain activity at functional MR imaging during the progression of hepatic encephalopathy. Radiology. 2012;264:187-195. [PMID: 22509052 DOI: 10.1148/radiol.12111429] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
442 Helmy A, Hayes PC. Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther. 2001;15:575-594. [PMID: 11328251 DOI: 10.1046/j.1365-2036.2001.00950.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
443 McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26:1226-32. [PMID: 3877665 DOI: 10.1136/gut.26.11.1226] [Cited by in Crossref: 372] [Cited by in F6Publishing: 347] [Article Influence: 10.3] [Reference Citation Analysis]
444 Bruix J, Cirera I, Calvet X, Fuster J, Bru C, Ayuso C, Vilana R, Boix L, Visa J, Rodés J. Surgical resection and survival in western patients with hepatocellular carcinoma. Journal of Hepatology 1992;15:350-5. [DOI: 10.1016/0168-8278(92)90067-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
445 Hanck C, Manigold T, Bocker U, Kurimoto M, Kolbel CB, Singer MV, Rossol S. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis. Gut. 2001;49:106-111. [PMID: 11413118 DOI: 10.1136/gut.49.1.106] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
446 Hanai T, Shiraki M, Nishimura K, Imai K, Suetsugu A, Takai K, Shimizu M, Naiki T, Moriwaki H. Free fatty acid as a marker of energy malnutrition in liver cirrhosis. Hepatol Res. 2014;44:218-228. [PMID: 23601060 DOI: 10.1111/hepr.12112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
447 De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology. 1994;20:1225-1230. [PMID: 7523273 DOI: 10.1002/hep.1840200519] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 3.3] [Reference Citation Analysis]
448 Merkel C, Bolognesi M, Bellon S, Sacerdoti D, Bianco S, Amodio P, Gatta A. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. Journal of Hepatology 1992;15:299-303. [DOI: 10.1016/0168-8278(92)90059-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
449 Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol 2019;32:626-32. [PMID: 31700241 DOI: 10.20524/aog.2019.0417] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
450 Ergün Y, Kurutaş EB, Ozdil B, Güneşaçar R, Ergün Y. Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis. Clin Res Hepatol Gastroenterol. 2011;35:303-308. [PMID: 21316327 DOI: 10.1016/j.clinre.2010.12.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
451 Lescure C, Estrade F, Pedrono M, Campillo-Gimenez B, Le Sourd S, Pracht M, Palard X, Bourien H, Muzellec L, Uguen T, Rolland Y, Garin E, Edeline J. ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3794. [PMID: 34359695 DOI: 10.3390/cancers13153794] [Reference Citation Analysis]
452 Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology. 1995;21:106-112. [PMID: 7806142 DOI: 10.1002/hep.1840210119] [Cited by in Crossref: 134] [Cited by in F6Publishing: 103] [Article Influence: 5.0] [Reference Citation Analysis]
453 Basile-Filho A, Nicolini EA, Auxiliadora-Martins M, Alkmim-Teixeira GC, Martinez EZ, Martins-Filho OA, de Castro e Silva O. Comparison of acute physiology and chronic health evaluation II death risk, Child-Pugh, Charlson, and model for end-stage liver disease indexes to predict early mortality after liver transplantation. Transplant Proc. 2011;43:1660-1664. [PMID: 21693253 DOI: 10.1016/j.transproceed.2010.11.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
454 Vulcano DS, Carvalhaes MA, Bakonyi Neto A. Evaluation of nutritional indicators and body composition in patients with advanced liver disease enrolled for liver transplantation. Acta Cir Bras. 2013;28:733-739. [PMID: 24114303 DOI: 10.1590/S0102-86502013001000008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
455 Prakoso E, Verran D, Dilworth P, Kyd G, Tang P, Tse C, Koorey DJ, Strasser SI, Stormon M, Shun A, Thomas G, Joseph D, Pleass H, Gallagher J, Allen R, Crawford M, McCaughan GW, Shackel NA. Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Intern Med J 2010;40:619-25. [PMID: 20840212 DOI: 10.1111/j.1445-5994.2010.02277.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
456 Tanaka H, Imai H, Higashi T, Murase K, Matsuhashi N, Yoshida K. Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report. Int J Surg Case Rep 2021;81:105715. [PMID: 33689973 DOI: 10.1016/j.ijscr.2021.105715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Ramond MJ, Valla D, Mosnier JF, Degott C, Bernuau J, Rueff B, Benhamou JP. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology 1989;10:488-93. [PMID: 2550345 DOI: 10.1002/hep.1840100415] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 3.6] [Reference Citation Analysis]
458 Kronfol Z, Litman HJ, Back-Madruga C, Bieliauskas LA, Lindsay KL, Lok AS, Fontana RJ; HALT-C Trial Group. No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C. J Affect Disord 2011;129:205-12. [PMID: 20889211 DOI: 10.1016/j.jad.2010.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
459 Sánchez-Rodríguez A, Criado M, Flores O, Olveira-Martín A, Martín-Oterino JA, Esteller A. Correlation of high levels of hyaluronan and cytokines (IL-1beta, IL-6, and TGF-beta) in ascitic fluid of cirrhotic patients. Dig Dis Sci 2000;45:2229-32. [PMID: 11215744 DOI: 10.1023/a:1026648805129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
460 Wang J, Huang R, Yan X, Li M, Chen Y, Xia J, Liu Y, Jia B, Zhu L, Zhang Z, Zhu C, Wu C. Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus-related diseases. Dig Liver Dis 2020;52:440-6. [PMID: 32008975 DOI: 10.1016/j.dld.2019.12.144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
461 Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Idèo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 1994;19:1115-1123. [PMID: 7513677 DOI: 10.1002/hep.1840190508] [Cited by in Crossref: 128] [Cited by in F6Publishing: 91] [Article Influence: 4.6] [Reference Citation Analysis]
462 Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, Hay JM, Erlinger S, Benhamou JP, Belghiti J, Valla D. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84-89. [PMID: 10385643 DOI: 10.1002/hep.510300125] [Cited by in Crossref: 164] [Cited by in F6Publishing: 119] [Article Influence: 7.1] [Reference Citation Analysis]
463 el-Bassiouni NE, el Bassiouny AE, el-Khayat HR, Akl MM, Omran SA. Hyperfibrinolysis in hepatosplenic schistosomiasis. J Clin Pathol 1996;49:990-3. [PMID: 9038736 DOI: 10.1136/jcp.49.12.990] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
464 Ahmad AH, Mahadeo KM. Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach. Front Oncol 2021;11:622630. [PMID: 33718184 DOI: 10.3389/fonc.2021.622630] [Reference Citation Analysis]
465 Belarmino G, Torrinhas RS, Magalhães NV, Heymsfield SB, Waitzberg DL. New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis. Nutrition 2021;84:111083. [PMID: 33418229 DOI: 10.1016/j.nut.2020.111083] [Reference Citation Analysis]
466 Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol. 2001;176:667-673. [PMID: 11222202 DOI: 10.2214/ajr.176.3.1760667] [Cited by in Crossref: 236] [Cited by in F6Publishing: 213] [Article Influence: 11.2] [Reference Citation Analysis]
467 Cauchy F, Fuks D, Belghiti J. HCC: current surgical treatment concepts. Langenbecks Arch Surg 2012;397:681-95. [DOI: 10.1007/s00423-012-0911-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
468 Crona DJ, Keisler MD, Walko CM. Regorafenib: A Novel Multitargeted Tyrosine Kinase Inhibitor for Colorectal Cancer and Gastrointestinal Stromal Tumors. Ann Pharmacother 2014;47:1685-96. [DOI: 10.1177/1060028013509792] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
469 Kihara Y, Ogami Y, Tabaru A, Unoki H, Otsuki M. Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose. J Gastroenterol. 1997;32:777-782. [PMID: 9430016 DOI: 10.1007/bf02936954] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
470 Machicao VI. Model for End-Stage Liver Disease–Sodium Score. Clinics in Liver Disease 2017;21:275-87. [DOI: 10.1016/j.cld.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
471 Kim SY, Yim HJ, Park SM, Kim JH, Jung SW, Kim JH, Seo YS, Yeon JE, Lee HS, Lee SW, Um SH, Byun KS, Choi JH, Ryu HS. Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients: Post-operative mortality in cirrhotics. Liver International 2011;31:222-8. [DOI: 10.1111/j.1478-3231.2010.02419.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
472 Egger ME, Gottumukkala V, Wilks JA, Soliz J, Ilmer M, Vauthey JN, Conrad C. Anesthetic and operative considerations for laparoscopic liver resection. Surgery. 2017;161:1191-1202. [PMID: 27545995 DOI: 10.1016/j.surg.2016.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
473 Cadranel J, Grippon P, Gargot D, Lunel F, Bernard B, Valla D, Opolon P. Spontaneous Dialytic Ultrafiltration with Intraperitoneal Reinfusion of the Concentrate in 15 Cirrhotic Patients with Intractable Ascites. Int J Artif Organs 1992;15:168-71. [DOI: 10.1177/039139889201500306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
474 Spahr L, Garcia I, Bresson-Hadni S, Rubbia-Brandt L, Guler R, Olleros M, Chvatchko Y, Hadengue A. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis. Liver Int 2004;24:582-7. [PMID: 15566508 DOI: 10.1111/j.1478-3231.2004.0967.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
475 Sponseller CA, Bacon BR, Di Bisceglie AM. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Liver Transpl. 2000;6:715-720. [PMID: 11084057 DOI: 10.1053/jlts.2000.18501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
476 Bakker CM, Metselaar HJ, Groenland TN, Gomes MJ, Knot EAR, Hesselink EJ, Schalm SW, Stibbe J, Terpstra OT. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: The role of the anhepatic period. Hepatology 1992;16:404-8. [DOI: 10.1002/hep.1840160219] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
477 Gao FY, Liu Y, Li XS, Ye XQ, Sun L, Geng MF, Wang R, Liu HM, Zhou XB, Gu LL, Liu YM, Wan G, Wang XB. Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B. World J Gastroenterol 2015; 21(27): 8373-8381 [PMID: 26217089 DOI: 10.3748/wjg.v21.i27.8373] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
478 Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg. 1998;4:416-423. [PMID: 9724480 DOI: 10.1002/lt.500040506] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
479 Patkowski W, Zieniewicz K, Skalski M, Krawczyk M. Correlation between selected prognostic factors and postoperative course in liver transplant recipients. Transplant Proc. 2009;41:3091-3102. [PMID: 19857685 DOI: 10.1016/j.transproceed.2009.09.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
480 Kida T, Umemura A, Kaneshita S, Sagawa R, Inoue T, Toyama S, Wada M, Kohno M, Oda R, Inaba T, Itoh Y, Kawahito Y. Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series. Mod Rheumatol 2020;30:1009-15. [PMID: 31625432 DOI: 10.1080/14397595.2019.1682787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
481 Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, Vincenti A, Stella A, Mancia G, Stramba-Badiale M. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond). 2009;116:851-859. [PMID: 19076059 DOI: 10.1042/cs20080325] [Cited by in Crossref: 59] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
482 Amer A, Amer ME. Enhanced monocyte tissue factor expression in hepatosplenic Schistosomiasis: . Blood Coagulation & Fibrinolysis 2002;13:43-7. [DOI: 10.1097/00001721-200201000-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
483 Berzigotti A, Rinaldi MF, Magalotti D, Morelli MC, Zappoli P, Andreone P, Rossi C, Zoli M. Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. Journal of Hepatology 2006;44:310-6. [DOI: 10.1016/j.jhep.2005.10.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
484 Worel N, Buser A, Greinix HT, Hägglund H, Navarro W, Pulsipher MA, Nicoloso de Faveri G, Bengtsson M, Billen A, Espino G, Fechter M, Giudice V, Hölig K, Kanamori H, Kodera Y, Leitner G, Netelenbos T, Niederwieser D, van Walraven SM, Rocha V, Torosian T, Vergueiro C, Weisdorf D, Yabe H, Halter JP. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biol Blood Marrow Transplant 2015;21:2052-60. [PMID: 26271194 DOI: 10.1016/j.bbmt.2015.08.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
485 Frye RF, Matzke GR, Schade R, Dixon R, Rabinovitz M. Effects of liver disease on the disposition of the opioid antagonist nalmefene*. Clin Pharmacol Ther 1997;61:15-23. [DOI: 10.1016/s0009-9236(97)90178-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
486 Kochhar R, Goenka MK, Mehta SK. Outcome of injection sclerotherapy using absolute alcohol in patients with cirrhosis, non-cirrhotic portal fibrosis, and extrahepatic portal venous obstruction. Gastrointest Endosc. 1991;37:460-464. [PMID: 1916169 DOI: 10.1016/s0016-5107(91)70780-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
487 Winata S, Liacos M, Crabtree A, Page A, Moran C. Electronic Medication Management System Introduction and Deprescribing Practice in Post-Acute Care. J Am Med Dir Assoc 2021;22:90-5. [PMID: 33234446 DOI: 10.1016/j.jamda.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
488 Amouzandeh M, Nowak G, Januszkiewicz A, Wernerman J, Rooyackers O, Norberg Å. Albumin mass balance and kinetics in liver transplantation. Crit Care 2018;22:152. [PMID: 29880012 DOI: 10.1186/s13054-018-2053-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
489 Peterson L, Marbury T, Marier J, Laliberte K. An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment. J Clin Pharm Ther 2013;38:518-23. [PMID: 24033615 DOI: 10.1111/jcpt.12094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
490 Schechter RB, Lemme EM, Coelho HS. Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment. Arq Gastroenterol. 2007;44:145-150. [PMID: 17962861 DOI: 10.1590/s0004-28032007000200012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
491 Rahbari NN, Garden OJ, Padbury R, Brooke-smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey J, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713-24. [DOI: 10.1016/j.surg.2010.10.001] [Cited by in Crossref: 1023] [Cited by in F6Publishing: 938] [Article Influence: 93.0] [Reference Citation Analysis]
492 Westaby D, Melia W, Hegarty J, Gimson AES, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 1986;6:673-5. [DOI: 10.1002/hep.1840060422] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 2.1] [Reference Citation Analysis]
493 Piscaglia F, Gaiani S, Gramantieri L, Zironi G, Siringo S, Bolondi L. Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation. Am J Gastroenterol. 1998;93:1925-1930. [PMID: 9772057 DOI: 10.1111/j.1572-0241.1998.00474.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
494 Biou D, Konan D, Féger J, Agneray J, Leroy Y, Cardon P, Fournet B, Durand G. Alterations in the carbohydrate moiety of alpha-1-acid glycoprotein purified from human cirrhotic ascitic fluid. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1987;913:308-12. [DOI: 10.1016/0167-4838(87)90140-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
495 Bräu N. Evaluation of the hepatitis C virus-infected patient: the initial encounter. Clin Infect Dis. 2013;56:853-860. [PMID: 23243172 DOI: 10.1093/cid/cis957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
496 Hong T, Jin BH, Kim CO, Yoo BW, Kim D, Lee JI, Kim BK, Ahn SH, Kim DY, Park JY, Park MS. Pharmacokinetics and safety of evogliptin in hepatically impaired patients. Br J Clin Pharmacol 2021;87:2757-66. [PMID: 33245796 DOI: 10.1111/bcp.14680] [Reference Citation Analysis]
497 Huo TI, Wu JC, Huang YH, Chiang JH, Lee PC, Chang FY, Lee SD. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment Pharmacol Ther. 2004;19:999-1007. [PMID: 15113367 DOI: 10.1111/j.1365-2036.2004.01936.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
498 Piscaglia F, Valgimigli M, Rapezzi C, Ferlito M, iani S, Siringo S, Gramantieri L, Bolondi L. Left ventricular volumes in liver cirrhosis. Digestive and Liver Disease 2000;32:392-7. [DOI: 10.1016/s1590-8658(00)80259-5] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
499 Tian Y, Lyu H, He Y, Xia Y, Li J, Shen F. Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC. J Gastrointest Surg 2018;22:615-23. [PMID: 29139083 DOI: 10.1007/s11605-017-3629-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
500 Orman ES, Ghabril MS, Desai AP, Nephew L, Patidar KR, Gao S, Xu C, Chalasani N. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00814-4. [PMID: 34311111 DOI: 10.1016/j.cgh.2021.07.032] [Reference Citation Analysis]
501 Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A, Palmer D, Yeo W, Mo F, Lai P, Iñarrairaegui M, Chan SL, Sangro B, Miksad R, Tada T, Kumada T, Toyoda H. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33:550-8. [PMID: 25512453 DOI: 10.1200/JCO.2014.57.9151] [Cited by in Crossref: 802] [Cited by in F6Publishing: 406] [Article Influence: 100.3] [Reference Citation Analysis]
502 Syue LS, Chen PL, Wu CJ, Lee NY, Lee CC, Li CW, Li MC, Tang HJ, Hsueh PR, Ko WC. Monomicrobial Aeromonas and Vibrio bacteremia in cirrhotic adults in southern Taiwan: Similarities and differences. J Microbiol Immunol Infect 2016;49:509-15. [PMID: 25070280 DOI: 10.1016/j.jmii.2014.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
503 Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol. 2002;97:1717-1721. [PMID: 12135024 DOI: 10.1111/j.1572-0241.2002.05831.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
504 Christians KK, Pitt HA, Rilling WS, Franco J, Quiroz FA, Adams MB, Wallace JR, Quebbeman EJ. Hepatocellular carcinoma: Multimodality management. Surgery 2001;130:554-60. [DOI: 10.1067/msy.2001.117106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
505 Tada T, Kumada T, Hiraoka A, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Tani J, Nakamura S, Nouso K, Tsutsui A, Nagano T, Takaaki T, Itokawa N, Okubo T, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y; Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinib. Sci Rep 2021;11:14474. [PMID: 34262065 DOI: 10.1038/s41598-021-93794-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Lammers WJ, Kowdley KV, Buuren HRV. Predicting outcome in primary biliary cirrhosis. Annals of Hepatology 2014;13:316-26. [DOI: 10.1016/s1665-2681(19)30838-5] [Cited by in Crossref: 31] [Article Influence: 3.9] [Reference Citation Analysis]
507 Miyoshi H, Tei H, Ashida K, Osaka N, Matsumoto A, Hirata I, Ohshiba S. Long-term prognosis of esophageal variceal cases treated with injection sclerotherapy. Gastroenterol Jpn 1989;24:469-75. [DOI: 10.1007/bf02773871] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
508 Zhang YF, Ji H, Lu HW, Lu L, Wang L, Wang JL, Li YM. Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension. World J Gastroenterol 2018; 24(39): 4499-4509 [PMID: 30356927 DOI: 10.3748/wjg.v24.i39.4499] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
509 Atkinson RJ, Hurlstone DP. Usefulness of prognostic indices in upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:233-242. [PMID: 18346681 DOI: 10.1016/j.bpg.2007.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
510 Yamada K, Izaki K, Sugimoto K, Mayahara H, Morita Y, Yoden E, Matsumoto S, Soejima T, Sugimura K. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:113-119. [PMID: 12909223 DOI: 10.1016/s0360-3016(03)00434-6] [Cited by in Crossref: 139] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
511 Cecco L, Antoniello S, Auletta M, Cerra M, Bonelli P. Pattern and concentration of free and acetylated polyamines in urine of cirrhotic patients. Int J Biol Markers 1992;7:52-8. [DOI: 10.1177/172460089200700108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
512 Verbeeck RK, Horsmans Y. Effect of hepatic insufficiency on pharmacokinetics and drug dosing. Pharm World Sci 1998;20:183-92. [PMID: 9820880 DOI: 10.1023/a:1008656930082] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
513 Santos BC, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Bioelectrical impedance vector analysis in patients on the waiting list for liver transplant: Associated factors and prognostic effects. Nutrition 2021;94:111528. [PMID: 34891107 DOI: 10.1016/j.nut.2021.111528] [Reference Citation Analysis]
514 Yamashiki N, Gaynor JJ, Kato T, Reddy KR, Sobhonslidsuk A, Levi D, Nishida S, Madariaga J, Nery J, Schiff ER. Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Am J Transplant. 2004;4:774-781. [PMID: 15084174 DOI: 10.1111/j.1600-6143.2004.00412.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
515 Pérez-cameo C, Vargas V, Castells L, Bilbao I, Campos-varela I, Gavaldà J, Pahissa A, Len O. Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: A cohort study: SBP in Liver Transplant Recipients. Liver Transpl 2014;20:856-63. [DOI: 10.1002/lt.23889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
516 Duah A, Nkrumah KN. Prevalence and predictors for spontaneous bacterial peritonitis in cirrhotic patients with ascites admitted at medical block in Korle-Bu Teaching Hospital, Ghana. Pan Afr Med J 2019;33:35. [PMID: 31384350 DOI: 10.11604/pamj.2019.33.35.18029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
517 Panes J, Bordas JM, Pique JM, Bosch J, Garcia-Pagan JC, Feu F, Casadevall M, Teres J, Rodes J. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology. 1992;103:1875-1882. [PMID: 1451980 DOI: 10.1016/0016-5085(92)91447-c] [Cited by in Crossref: 87] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
518 Wang Y, Bajorek B. Selecting antithrombotic therapy for stroke prevention in atrial fibrillation: Health professionals' feedback on a decision support tool. Health Informatics J 2018;24:309-22. [PMID: 30068267 DOI: 10.1177/1460458216675498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
519 Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, Ayuso C, Llovet JM, Real MI, Bruix J. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol. 2012;56:1330-1335. [PMID: 22314428 DOI: 10.1016/j.jhep.2012.01.008] [Cited by in Crossref: 284] [Cited by in F6Publishing: 263] [Article Influence: 28.4] [Reference Citation Analysis]
520 Shi M, Wei J, Dong J, Meng W, Ma J, Wang T, Wang N, Wang Y. Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis. Mol Med Rep. 2015;11:121-126. [PMID: 25323532 DOI: 10.3892/mmr.2014.2681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
521 Sugimura T, Tsuji Y, Sakamoto M, Kotoh K, Fukutomi T, Sakai H, Sakamoto S, Akazawa K, Nose Y, Nawata H. Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s. J Gastroenterol Hepatol 1994;9:154-61. [DOI: 10.1111/j.1440-1746.1994.tb01236.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
522 Fernández Fernández N, Linares Torres P, Joáo Matias D, Jorquera Plaza F, Olcoz Goñi JL. [Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation]. Gastroenterol Hepatol 2016;39:305-10. [PMID: 26596370 DOI: 10.1016/j.gastrohep.2015.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
523 Hafeez M, Nadeem M, Ahmed M, Faheem-Ur-Rehman. Hepatocellular Carcinoma (HCC), Where do we stand? Current situation. Pak J Med Sci 2020;36:344-8. [PMID: 32292431 DOI: 10.12669/pjms.36.3.1594] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
524 Barakat M. Non-pulsatile hepatic and portal vein waveforms in patients with liver cirrhosis: concordant and discordant relationships. Br J Radiol 2004;77:547-50. [PMID: 15238399 DOI: 10.1259/bjr/19413822] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
525 Valerio C, Theocharidou E, Davenport A, Agarwal B. Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion. World J Hepatol 2016; 8(7): 345-354 [PMID: 26981172 DOI: 10.4254/wjh.v8.i7.345] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
526 Vickers C, Rhodes J, Chesner I, Hillenbrand P, Dawson J, Cockel R, Adams D, O'connor H, Dykes P, Bradby H, Valori R, Elias E. Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy. Journal of Hepatology 1994;21:81-7. [DOI: 10.1016/s0168-8278(94)80141-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
527 Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis. Journal of Gastroenterology and Hepatology 2008;23:1250-8. [DOI: 10.1111/j.1440-1746.2008.05499.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
528 Turner WW, Ellman BA. Transhepatic embolization in patients with acute variceal hemorrhage. The American Journal of Surgery 1981;142:731-4. [DOI: 10.1016/0002-9610(81)90322-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
529 Rauws EA, Kool G, Bolwerk C. New approaches to endoscopic therapy for a haemostasis upper GI bleed. Scand J Gastroenterol Suppl. 1996;218:116-123. [PMID: 8865461 DOI: 10.3109/00365529609094741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
530 Nolla-Salas J, Almela M, Gasser I, Latorre C, Salvadó M, Coll P. Spontaneous Listeria monocytogenes peritonitis: a population-based study of 13 cases collected in Spain. Am J Gastroenterol 2002;97:1507-11. [PMID: 12094874 DOI: 10.1111/j.1572-0241.2002.05798.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
531 Cerini F, Gonzalez JM, Torres F, Puente Á, Casas M, Vinaixa C, Berenguer M, Ardevol A, Augustin S, Llop E. Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology. 2015;62:575-583. [PMID: 25773591 DOI: 10.1002/hep.27783] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
532 Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, Cheng JS, Lai KH. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc. 2004;59:333-338. [PMID: 14997127 DOI: 10.1016/s0016-5107(03)02819-0] [Cited by in Crossref: 106] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
533 Figueiredo FA, De Mello Perez R, Kondo M. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol. 2005;20:209-216. [PMID: 15683423 DOI: 10.1111/j.1440-1746.2004.03544.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
534 Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, Berkes JL, Cotler SJ. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2013;24:411-420, 420.e1-4; quiz 421. [PMID: 23312989 DOI: 10.1016/j.jvir.2012.10.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
535 Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386:1576-1587. [PMID: 26423181 DOI: 10.1016/s0140-6736(15)00309-8] [Cited by in Crossref: 153] [Cited by in F6Publishing: 59] [Article Influence: 21.9] [Reference Citation Analysis]
536 Deibert P, Allgaier HP, Loesch S, Müller C, Olschewski M, Hamm H, Maier KP, Blum HE. Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol 2006;6:15. [PMID: 16638132 DOI: 10.1186/1471-230X-6-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
537 Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16:195-203. [PMID: 15713920 DOI: 10.1097/01.rvi.0000142602.79459.90] [Cited by in Crossref: 87] [Cited by in F6Publishing: 19] [Article Influence: 5.1] [Reference Citation Analysis]
538 Nicolás JM, García G, Fatjó F, Sacanella E, Tobías E, Badía E, Estruch R, Fernández-Solà J. Influence of nutritional status on alcoholic myopathy. Am J Clin Nutr 2003;78:326-33. [PMID: 12885717 DOI: 10.1093/ajcn/78.2.326] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
539 Ota K, Shijo H, Kokawa H, Kubara K, Kim T, Akiyoshi N, Yokoyama M, Okumura M. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J Gastroenterol Hepatol 1995;10:198-204. [PMID: 7787167 DOI: 10.1111/j.1440-1746.1995.tb01078.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
540 Xie W, Cao Y, Xu M, Wang J, Zhou C, Yang X, Geng X, Zhang W, Li N, Cheng J. Prognostic Significance of Elevated Cholestatic Enzymes for Fibrosis and Hepatocellular Carcinoma in Hospital Discharged Chronic Viral Hepatitis Patients. Sci Rep 2017;7:10289. [PMID: 28860489 DOI: 10.1038/s41598-017-11111-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
541 Moltó J, Llibre JM, Ribera E, Mínguez C, del Río JS, Pedrol E, Vallecillo G, Cedeño S, Valle M, Miranda C, Negredo E, Clotet B; SQV-HEP Study Group. Saquinavir exposure in HIV-infected patients with chronic viral hepatitis. J Antimicrob Chemother 2009;63:992-7. [PMID: 19279052 DOI: 10.1093/jac/dkp070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
542 Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992;16:132-137. [PMID: 1352268 DOI: 10.1002/hep.1840160122] [Cited by in Crossref: 294] [Cited by in F6Publishing: 259] [Article Influence: 9.8] [Reference Citation Analysis]
543 Chakraborty D, Akbari A, Knoll GA, Flemming JA, Lowe C, Akbari S, White CA. Serum BTP concentrations are not affected by hepatic dysfunction. BMC Nephrol 2018;19:87. [PMID: 29653513 DOI: 10.1186/s12882-018-0881-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
544 Jiang L, Xie L, Li G, Xie H, Fang Z, Cai X, Chen Y. Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterol 2021;21:156. [PMID: 33827427 DOI: 10.1186/s12876-021-01743-3] [Reference Citation Analysis]
545 Weindelmayer J, Mengardo V, Veltri A, Baiocchi GL, Giacopuzzi S, Verlato G, de Manzoni G; Italian Research Group for Gastric Cancer (GIRCG). Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial. Trials 2021;22:152. [PMID: 33596959 DOI: 10.1186/s13063-021-05102-1] [Reference Citation Analysis]
546 Lei Q, Ao K, Zhang Y, Ma D, Ding D, Ke C, Chen Y, Luo J, Meng Z. Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure. Clinics (Sao Paulo). 2017;72:686-692. [PMID: 29236915 DOI: 10.6061/clinics/2017(11)07] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
547 Keating JJ, Johnson RD, Johnson PJ, Williams R. Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation. Gut 1985;26:1359-63. [PMID: 3910522 DOI: 10.1136/gut.26.12.1359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
548 González-Calvin JL, Mundi JL, Casado-Caballero FJ, Abadia AC, Martin-Ibañez JJ. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. J Clin Endocrinol Metab 2009;94:4844-50. [PMID: 19897681 DOI: 10.1210/jc.2009-0835] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
549 Dunkel N, Pittet D, Tovmirzaeva L, Suvà D, Bernard L, Lew D, Hoffmeyer P, Uçkay I. Short duration of antibiotic prophylaxis in open fractures does not enhance risk of subsequent infection. The Bone & Joint Journal 2013;95-B:831-7. [DOI: 10.1302/0301-620x.95b6.30114] [Cited by in Crossref: 61] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
550 Sakata M, Kawaguchi T, Taniguchi E, Nakayama A, Ishizaki S, Sonaka I, Nakamura T, Itou M, Oriishi T, Abe M, Yanagimoto C, Koga H, Sata M. Oxidized albumin is associated with water retention and severity of disease in patients with chronic liver diseases. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2010;5:e247-53. [DOI: 10.1016/j.eclnm.2010.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
551 Simsek I, Aslan G, Akarsu M, Koseoglu H, Esen A. Assessment of sexual functions in patients with chronic liver disease. Int J Impot Res 2005;17:343-5. [DOI: 10.1038/sj.ijir.3901316] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
552 Hernández-Guerra M, López E, Bellot P, Piera C, Turnes J, Abraldes JG, Bosch J, García-Pagán JC. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology 2006;43:27-33. [PMID: 16374846 DOI: 10.1002/hep.20990] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
553 Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery. 2007;141:598-609. [PMID: 17462459 DOI: 10.1016/j.surg.2006.11.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
554 Okumoto K, Hattori E, Tamura K, Kiso S, Watanabe H, Saito K, Saito T, Togashi H, Kawata S. Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma. Liver Int. 2004;24:21-28. [PMID: 15101997 DOI: 10.1111/j.1478-3231.2004.00882.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.3] [Reference Citation Analysis]
555 Bernardi M, Di Marco C, Trevisani F, De Collibus C, Fornalé L, Baraldini M, Andreone P, Cursaro C, Zacá F, Ligabue A. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology. 1992;16:341-346. [PMID: 1386333 DOI: 10.1002/hep.1840160210] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 2.0] [Reference Citation Analysis]
556 Yu X, Zheng Y, Deng Y, Li J, Guo R, Su M, Ming D, Lin Z, Zhang J, Su Z. Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure. Medicine (Baltimore) 2016;95:e3405. [PMID: 27100428 DOI: 10.1097/MD.0000000000003405] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
557 Nedredal GI, Yin M, McKenzie T, Lillegard J, Luebke-Wheeler J, Talwalkar J, Ehman R, Nyberg SL. Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging 2011;34:79-87. [PMID: 21608066 DOI: 10.1002/jmri.22610] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
558 Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2005;20:1494-1502. [PMID: 16174064 DOI: 10.1111/j.1440-1746.2005.03878.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
559 Müller M, Rieger A, Willmann O, Lautz H, Balks H, Von zur Mühlen A, Canzler H, Schmidt F. Metabolic responses to lipid infusions in patients with liver cirrhosis. Clinical Nutrition 1992;11:193-206. [DOI: 10.1016/0261-5614(92)90028-o] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
560 Mannaioni G, Carpenedo R, Corradetti R, Carlà V, Venturini I, Baraldi M, Zeneroli ML, Moroni F. Tryptophan Metabolism and Hepatic Encephalopathy. In: Huether G, Kochen W, Simat TJ, Steinhart H, editors. Tryptophan, Serotonin, and Melatonin. Boston: Springer US; 1999. pp. 155-67. [DOI: 10.1007/978-1-4615-4709-9_21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
561 Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol. 2008;23:482-490. [PMID: 18086115 DOI: 10.1111/j.1440-1746.2007.05262.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
562 Kariyama K, Nouso K, Hiraoka A, Wakuta A, Oonishi A, Kuzuya T, Toyoda H, Tada T, Tsuji K, Itobayashi E, Ishikawa T, Takaguchi K, Tsutsui A, Shimada N, Kudo M, Kumada T. EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis. Liver Cancer 2020;9:734-43. [PMID: 33442542 DOI: 10.1159/000508971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
563 Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry MP. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation? Prog Transplant 2011;21:207-14. [PMID: 21977881 DOI: 10.7182/prtr.21.3.c508417x010g552n] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
564 de Vries PJ, Hooge PD, Hoekstra JB, Hattum JV. Blunted postprandial reaction of portal venous flow in chronic liver disease, assessed with duplex Doppler: significance for prognosis. Journal of Hepatology 1994;21:966-73. [DOI: 10.1016/s0168-8278(05)80603-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
565 Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707-1715. [PMID: 18691193 DOI: 10.1111/j.1572-0241.2008.01861.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 13.0] [Reference Citation Analysis]
566 Terziyski K, Andonov V, Marinov B, Kostianev S. Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis. Clin Exp Pharmacol Physiol. 2008;35:135-140. [PMID: 18197891 DOI: 10.1111/j.1440-1681.2007.04751.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
567 Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol 2016; 22(3): 1260-1278 [PMID: 26811663 DOI: 10.3748/wjg.v22.i3.1260] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
568 Söderlund C, Backman L, Erwald R, Forsgren L, Marions O, Wiechel K. Sclerotherapy of Esophageal Varices: An Endoscopic and Portographic Study. Hepatology 1984;4:877-84. [DOI: 10.1002/hep.1840040514] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
569 Chang T, Lee F, Tsai Y, Lai K, Chao Y, Hsia H, Lin H, Wang S, Lee S, Lo K. A randomized controlled study of low-dose and high-dose terlipressin in the control of acute oesophageal variceal haemorrhage. J Gastroenterol Hepatol 1991;6:481-4. [DOI: 10.1111/j.1440-1746.1991.tb00892.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
570 Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG, Gentilini P. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992;103:641-6. [DOI: 10.1016/0016-5085(92)90859-w] [Cited by in Crossref: 74] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
571 Schöniger-hekele M, Ramskogler K, Hartl D, Lesch OM, Müller C. Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease? Wien Med Wochenschr 2006;156:216-22. [DOI: 10.1007/s10354-005-0238-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
572 Da Silva LC, da Fonseca LE, Carrilho FJ, Alves VA, Sitnik R, Pinho JR. Predictive factors for response to lamivudine in chronic hepatitis B. Rev Inst Med Trop Sao Paulo. 2000;42:189-196. [PMID: 10968881 DOI: 10.1590/s0036-46652000000400003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
573 Thabut D, Trabut J, Massard J, Rudler M, Muntenau M, Messous D, Poynard T. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int 2006;26:271-8. [DOI: 10.1111/j.1478-3231.2005.01227.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
574 Van Deusen MA, Abdalla EK, Vauthey JN, Roh MS. Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 2005;5:377-83. [PMID: 15934814 DOI: 10.1586/14737159.5.3.377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
575 Nimer A, M P, D G, Y B, G S. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999; 5(4): 296-300 [PMID: 11819451 DOI: 10.3748/wjg.v5.i4.296] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 18] [Article Influence: 0.1] [Reference Citation Analysis]
576 Ohmann C, Stöltzing H, Wins L, Busch E, Thon K. Prognostic Scores in Oesophageal or Gastric Variceal Bleeding. Scandinavian Journal of Gastroenterology 2009;25:501-12. [DOI: 10.3109/00365529009095522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
577 Peeters P, Bockbrader H, Spaans E, Dogterom P, Lasseter K, Marbury T, Gibson GL, de Greef R. Asenapine pharmacokinetics in hepatic and renal impairment. Clin Pharmacokinet 2011;50:471-81. [PMID: 21651314 DOI: 10.2165/11590490-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
578 Kondili LA, Chionne P, Porcaro A, Madonna E, Taffon S, Resuli B, Taliani G, Rapicetta M. Seroprevalence of hepatitis E virus (HEV) antibody and the possible association with chronic liver disease: a case-control study in Albania. Epidemiol Infect. 2006;134:95-101. [PMID: 16409655 DOI: 10.1017/s095026880500470x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
579 Au KP, Chan SC, Chok KS, Chan AC, Cheung TT, Ng KK, Lo CM. Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy. HPB Surg 2017;2017:2948030. [PMID: 28951631 DOI: 10.1155/2017/2948030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
580 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
581 Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27-34. [PMID: 15954118 DOI: 10.1002/hep.20728] [Cited by in Crossref: 308] [Cited by in F6Publishing: 270] [Article Influence: 18.1] [Reference Citation Analysis]
582 Guest T, Tantam G, Donlin N, Tantam K, McMillan H, Tillyard A. An observational cohort study of triage for critical care provision during pandemic influenza: 'clipboard physicians' or 'evidenced based medicine'? Anaesthesia 2009;64:1199-206. [PMID: 19825055 DOI: 10.1111/j.1365-2044.2009.06084.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
583 Chattopadhyay N, Riecke K, Ligges S, Zimmermann T, Halabi A, Schultze-Mosgau MH. Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open-label, single-dose, parallel-group study. Br J Clin Pharmacol 2019;85:2011-21. [PMID: 31112623 DOI: 10.1111/bcp.13992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
584 Martínez Cerezo FJ, Mreish Tatros G, Vida Mombiela F, Tomas A, Abad Á, Campo R, Saló J, Boadas J, Baños F, Rigau J, Sabat M, Fàbregas S, Vidal L, Planella M, Castellví JM, Giné J, Saperas E, Torra S, Creix AJ, Torres M, Rey J, García V, Laguna JC, Pascual D, Manso C. Asistencia urgente a los pacientes con hemorragia digestiva alta en los hospitales comarcales catalanes. Gastroenterología y Hepatología 2011;34:605-10. [DOI: 10.1016/j.gastrohep.2011.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
585 Riestra S, Rodriguez M, Delgado M, Suárez A, González N, de la Mata M, Diaz G, Miño-Fugarolas G, Rodrigo L. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma. J Clin Gastroenterol 1998;26:200-3. [PMID: 9600369 DOI: 10.1097/00004836-199804000-00010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 1.6] [Reference Citation Analysis]
586 Strunin L, Davies JM. The liver and anaesthesia. Can Anaesth Soc J 1983;30:208-17. [DOI: 10.1007/bf03009354] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
587 Marbury T, Dowell JA, Seltzer E, Buckwalter M. Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment. The Journal of Clinical Pharmacology 2009;49:465-76. [DOI: 10.1177/0091270008330162] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
588 Urata Y, Kubo S, Takemura S, Uenishi T, Kodai S, Shinkawa H, Sakae M, Kaneda K, Ohata K, Nozawa A. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012;19:685-696. [PMID: 22203455 DOI: 10.1007/s00534-011-0489-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
589 Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643-1651. [PMID: 16697728 DOI: 10.1053/j.gastro.2006.02.008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 127] [Article Influence: 11.0] [Reference Citation Analysis]
590 Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol. 1991;13:274-278. [PMID: 1808219 DOI: 10.1016/0168-8278(91)90068-m] [Cited by in Crossref: 67] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
591 Dutta U, Byth K, Kench J, Khan MH, Coverdale SA, Weltman M, Lin R, Liddle C, Farrell GC. Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study. Aust N Z J Med 1999;29:300-7. [PMID: 10868491 DOI: 10.1111/j.1445-5994.1999.tb00710.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
592 Sabbà C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, Bolondi L. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995;21:428-33. [PMID: 7843716 DOI: 10.1002/hep.1840210225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 0.3] [Reference Citation Analysis]
593 Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases. Radiology. 2003;227:89-94. [PMID: 12601199 DOI: 10.1148/radiol.2272020193] [Cited by in Crossref: 209] [Cited by in F6Publishing: 185] [Article Influence: 11.0] [Reference Citation Analysis]
594 Berry PA, Thomson SJ, Rahman TM, Ala A. Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis. Aliment Pharmacol Ther. 2013;37:174-182. [PMID: 23157692 DOI: 10.1111/apt.12133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
595 Sladen RN. Anesthetic Concerns for the Patient with Renal or Hepatic Disease: . ASA Refresher Courses in Anesthesiology 2001;29:213-28. [DOI: 10.1097/00126869-200129010-00020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
596 Andrade HB, da Silva I, Ramos GV, Medeiros DM, Ho YL, de Carvalho FB, Bozza FA, Japiassú AM. Short- and medium-term prognosis of HIV-infected patients receiving intensive care: a Brazilian multicentre prospective cohort study. HIV Med 2020;21:650-8. [PMID: 32876389 DOI: 10.1111/hiv.12939] [Reference Citation Analysis]
597 Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol. 2008;15:1383-1391. [PMID: 18320284 DOI: 10.1245/s10434-008-9851-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
598 Aparisi L, Sabater L, Del-Olmo J, Sastre J, Serra MA, Campello R, Bautista D, Wassel A, Rodrigo JM. Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects? World J Gastroenterol 2008; 14(40): 6171-6179 [PMID: 18985807 DOI: 10.3748/wjg.14.6171] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
599 MacDougall BR, Westaby D, Theodossi A, Dawson JL, Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982;1:124-127. [PMID: 6119510 DOI: 10.1016/s0140-6736(82)90378-6] [Cited by in Crossref: 222] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
600 Zhang ZQ, Yang B, Zou H, Xiong L, Miao XY, Wen Y, Zhou JJ. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients. Medicine (Baltimore) 2019;98:e15168. [PMID: 30985698 DOI: 10.1097/MD.0000000000015168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
601 Bolognesi M, Sacerdoti D, Mescoli C, Bombonato G, Cillo U, Merenda R, Giacomelli L, Merkel C, Rugge M, Gatta A. Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol. 2007;42:256-262. [PMID: 17327946 DOI: 10.1080/00365520600880914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
602 Weber T, Sendt W, Grube T, Scheele J, Weber T. Coagulation profiles and intraoperative substitution requirements during elective piggyback liver transplantation with prophylactic antifibrinolytic therapy. Transplant Int 2002;15:310-6. [DOI: 10.1111/j.1432-2277.2002.tb00170.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
603 Tietge U. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation. Liver Transplantation 2001;7:1015-22. [DOI: 10.1053/jlts.2001.29349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
604 Wrenn K. The lowly nasogastric tube: Still appropriate after all these years (at times). The American Journal of Emergency Medicine 1993;11:84-9. [DOI: 10.1016/0735-6757(93)90068-m] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
605 De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, Forlino M, Farcomeni A, Riggio O. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2018;33:704-9. [PMID: 28753738 DOI: 10.1111/jgh.13907] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
606 Burroughs AK, Mccormick P, Hughes MD, Sprengers D, D'heygere F, Mcintyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990;99:1388-95. [DOI: 10.1016/0016-5085(90)91166-4] [Cited by in Crossref: 184] [Cited by in F6Publishing: 151] [Article Influence: 5.8] [Reference Citation Analysis]
607 Chaves GV, Peres WA, Gonçalves JC, Ramalho A. Vitamin A and retinol-binding protein deficiency among chronic liver disease patients. Nutrition. 2015;31:664-668. [PMID: 25837210 DOI: 10.1016/j.nut.2014.10.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
608 Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885. [PMID: 12740346 DOI: 10.1136/gut.52.6.879] [Cited by in Crossref: 188] [Cited by in F6Publishing: 177] [Article Influence: 9.9] [Reference Citation Analysis]
609 Spina G, Santambrogio R. The role of portosystemic shunting in the management of portal hypertension. Baillière's Clinical Gastroenterology 1992;6:497-515. [DOI: 10.1016/0950-3528(92)90035-d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Qiang L, Huikai L, Butt K, Wang PP, Hao X. Factors Associated with Disease Survival after Surgical Resection in Chinese Patients with Hepatocellular Carcinoma. World J Surg 2006;30:439-45. [DOI: 10.1007/s00268-005-0608-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
611 Razek AA, Massoud SM, Azziz MR, El-Bendary MM, Zalata K, Motawea EM. Prediction of esophageal varices in cirrhotic patients with apparent diffusion coefficient of the spleen. Abdom Imaging. 2015;40:1465-1469. [PMID: 25732406 DOI: 10.1007/s00261-015-0391-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
612 Harada N, Shirabe K, Maeda T, Kayashima H, Ishida T, Maehara Y. Blood Transfusion is Associated with Recurrence of Hepatocellular Carcinoma After Hepatectomy in Child–Pugh Class A Patients. World J Surg 2015;39:1044-51. [DOI: 10.1007/s00268-014-2891-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
613 Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis. J Trauma 2011;71:6-11. [PMID: 21818010 DOI: 10.1097/TA.0b013e31822311c5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
614 Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer. 2002;95:2539-2545. [PMID: 12467068 DOI: 10.1002/cncr.11002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
615 Šebeková K, Kupčová V, Schinzel R, Heidland A. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantation. Journal of Hepatology 2002;36:66-71. [DOI: 10.1016/s0168-8278(01)00232-x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
616 Gunnarsson L, Eleborg L, Eriksson LS. Anesthesia for liver transplantation in patients with arterial hypoxemia. Transplant Int 1990;3:103-7. [DOI: 10.1111/j.1432-2277.1990.tb01902.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
617 Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care. 2011;17:165-169. [PMID: 21326095 DOI: 10.1097/mcc.0b013e328344b42d] [Cited by in Crossref: 115] [Cited by in F6Publishing: 49] [Article Influence: 10.5] [Reference Citation Analysis]
618 Dickinson J, Lewand M, Sawamoto T, Krauwinkel W, Schaddelee M, Keirns J, Kerbusch V, Moy S, Meijer J, Kowalski D, Morton R, Lasseter K, Riff D, Kupčová V, van Gelderen M. Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron. Clinical Drug Investigation 2013;33:11-23. [DOI: 10.1007/s40261-012-0031-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
619 Buster EH, Schalm SW, Janssen HL. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues. Best Pract Res Clin Gastroenterol. 2008;22:1093-1108. [PMID: 19187869 DOI: 10.1016/j.bpg.2008.11.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
620 Santambrogio R, Cigala C, Barabino M, Maggioni M, Scifo G, Bruno S, Bertolini E, Opocher E, Bulfamante G. Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathology. Liver Int 2018;38:312-20. [PMID: 28732141 DOI: 10.1111/liv.13524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
621 Zironi G, Rossi C, Siringo S, Galaverni C, Gaiani S, Piscaglia F, Bolondi L. Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. Liver 1996;16:225-34. [DOI: 10.1111/j.1600-0676.1996.tb00733.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
622 Cho CS. Prognostication systems as applied to primary and metastatic hepatic malignancies. Surg Oncol Clin N Am 2015;24:41-56. [PMID: 25444468 DOI: 10.1016/j.soc.2014.09.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
623 Eiró N, Altadill A, Juárez LM, Rodríguez M, González LO, Atienza S, Bermúdez S, Fernandez-Garcia B, Fresno-Forcelledo MF, Rodrigo L. Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. Hepatol Res. 2014;44:769-778. [PMID: 23742263 DOI: 10.1111/hepr.12180] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
624 Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 2009;13:2268-75. [PMID: 19662460 DOI: 10.1007/s11605-009-0977-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
625 Forster J, Delcore R, Payne KM, Siegel EL. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. The American Journal of Surgery 1994;168:592-7. [DOI: 10.1016/s0002-9610(05)80128-x] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
626 Hoover R, Marbury TC, Preston RA, Quintas M, Lawrence LE, Paulson SK, Luke DR, Cammarata SK. Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment. J Clin Pharmacol 2017;57:328-35. [PMID: 27570245 DOI: 10.1002/jcph.817] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
627 McCullough AJ, O’Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2022-2036. [PMID: 9820369 DOI: 10.1111/j.1572-0241.1998.00587.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 153] [Article Influence: 7.0] [Reference Citation Analysis]
628 Bao Q, Wang B, Yu L, Weng H, Ge J, Li L. A modified prognostic score for critically ill patients with cirrhosis: An observational study. J Gastroenterol Hepatol 2016;31:450-8. [PMID: 26251873 DOI: 10.1111/jgh.13076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
629 Bruix J, Llovet JM. Locoregional treatments for hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:611-622. [PMID: 10654923 DOI: 10.1053/bega.1999.0051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
630 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 202] [Article Influence: 21.1] [Reference Citation Analysis]
631 Helton WS, Johansen K. Portal Hypertension and Bleeding Esophagogastric Varices. Annals of Vascular Surgery 1996;10:415-26. [DOI: 10.1007/bf02286790] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
632 Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Bañares F, Xiol X, Gassull MA. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990;98:715-20. [PMID: 2105256 DOI: 10.1016/0016-5085(90)90293-a] [Cited by in Crossref: 240] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
633 Ferron GM, Preston RA, Noveck RJ, Pockros P, Mayer P, Getsy J, Turner M, Abell M, Paul J. Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction. Clin Ther 2001;23:1180-92. [PMID: 11558857 DOI: 10.1016/s0149-2918(01)80100-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
634 Saitoh O, Sugi K, Kojima K, Matsumoto H, Nakagawa K, Kayazawa M, Tanaka S, Teranishi T, Hirata I, Katsu KI. Increased prevalence of intestinal inflammation in patients with liver cirrhosis. World J Gastroenterol 1999; 5(5): 391-396 [PMID: 11819475 DOI: 10.3748/wjg.v5.i5.391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
635 Woitas RP, Stoffel-wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr H, Spengler U, Bidlingmaier F, Sauerbruch T. Correlation of Serum Concentrations of Cystatin C and Creatinine to Inulin Clearance in Liver Cirrhosis. Clinical Chemistry 2000;46:712-5. [DOI: 10.1093/clinchem/46.5.712] [Cited by in Crossref: 93] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
636 Huo T, Wu J, Lui W, Huang Y, Lee P, Chiang J, Chang F, Lee S. Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment. Am J Gastroenterology 2004;99:1479-87. [DOI: 10.1111/j.1572-0241.2004.30024.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
637 Saiz de la Hoya P, Portilla J, Marco A, García-Guerrero J, Faraco I, Antón J, de Juan J, Pozo E. Directly observed therapy for chronic hepatitis C: a randomized clinical trial in the prison setting. Gastroenterol Hepatol 2014;37:443-51. [PMID: 24786935 DOI: 10.1016/j.gastrohep.2014.03.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
638 Yamashiki N, Kato T, Bejarano PA, Berho M, Montalvo B, Shebert RT, Goodman ZD, Seki T, Schiff ER, Tzakis AG. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol. 2003;98:2052-2059. [PMID: 14499787 DOI: 10.1111/j.1572-0241.2003.07642.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
639 Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol. 2005;39:540-543. [PMID: 15942443 DOI: 10.1097/01.mcg.0000165671.25272.0f] [Cited by in Crossref: 297] [Cited by in F6Publishing: 288] [Article Influence: 17.5] [Reference Citation Analysis]
640 Franck M, Thon C, Schütte K, Malfertheiner P, Link A. Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function. World J Hepatol 2020; 12(11): 1031-1045 [PMID: 33312427 DOI: 10.4254/wjh.v12.i11.1031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
641 Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 2010;138:136-46. [PMID: 19766643 DOI: 10.1053/j.gastro.2009.09.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
642 Fabbri A, Magalotti D, Brizi M, Bianchi G, Zoli M, Marchesini G. Prostaglandin E1 infusion and functional hepatic flow in control subjects and in patients with cirrhosis. Dig Dis Sci. 1999;44:377-384. [PMID: 10063926 DOI: 10.1023/A:1026670921331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
643 Cabibbo G, Palmeri L, Palmeri S, Craxì A. Should cirrhosis change our attitude towards treating non-hepatic cancer? Liver Int. 2012;32:21-27. [PMID: 22098398 DOI: 10.1111/j.1478-3231.2011.02629.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
644 Körner T, Kropf J, Kosche B, Kristahl H, Jaspersen D, Gressner AM. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol. 2003;39:947-953. [PMID: 14642610 DOI: 10.1016/s0168-8278(03)00431-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
645 Al-Husein BA, Al-Azzam SI, Alzoubi KH, Khabour OF, Nusair MB, Alzayadeen S. Investigating the Effect of Demographics, Clinical Characteristics, and Polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on Clopidogrel Resistance. J Cardiovasc Pharmacol 2018;72:296-302. [PMID: 30422888 DOI: 10.1097/FJC.0000000000000627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
646 Fröhlich S, Murphy N, Kong T, Ffrench-o’carroll R, Conlon N, Ryan D, Boylan J. Alcoholic liver disease in the intensive care unit: Outcomes and predictors of prognosis. Journal of Critical Care 2014;29:1131.e7-1131.e13. [DOI: 10.1016/j.jcrc.2014.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
647 Blanco R, Inza I, Merino M, Quiroga J, Larrañaga P. Feature selection in Bayesian classifiers for the prognosis of survival of cirrhotic patients treated with TIPS. Journal of Biomedical Informatics 2005;38:376-88. [DOI: 10.1016/j.jbi.2005.05.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
648 Nozoe T, Matsumata T, Sugimachi K. Dysphagia after prophylactic endoscopic injection sclerotherapy for oesophageal varices: Not fatal but a distressing complication. Journal of Gastroenterology and Hepatology 2001;15:320-3. [DOI: 10.1046/j.1440-1746.2000.02128.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
649 Kays JK, Milgrom DP, Butler JR, Liang TW, Valsangkar NP, Wojcik B, Frye CC, Maluccio MA, Kubal CA, Koniaris LG. Specialized care improves outcomes for patients with cirrhosis who require general surgical operations. PLoS One 2019;14:e0223454. [PMID: 31618218 DOI: 10.1371/journal.pone.0223454] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
650 Elwakil R, Montasser MF, Abdelhakam SM, Ibrahim WA. N-butyl-2-cyanoacrylate, iso-amyl-2-cyanoacrylate and hypertonic glucose with 72% chromated glycerin in gastric varices. World J Gastrointest Endosc 2015; 7(4): 411-416 [PMID: 25901221 DOI: 10.4253/wjge.v7.i4.411] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
651 Cholongitas E, Ilonidis G. Transmission of varicella-zoster virus originating from a patient with localized herpes zoster: Implications for infection control? Am J Infect Control 2010;38:669-70. [PMID: 20868936 DOI: 10.1016/j.ajic.2010.02.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
652 Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant 2020;25:99-103. [PMID: 32073495 DOI: 10.1097/MOT.0000000000000732] [Reference Citation Analysis]
653 Chung RT, Jaffe DL, Friedman LS. Complications of Chronic Liver Disease. Critical Care Clinics 1995;11:431-63. [DOI: 10.1016/s0749-0704(18)30075-7] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
654 Seno H, Ito K, Kojima K, Nakajima N, Chiba T. Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. J Gastroenterol Hepatol. 1999;14:811-816. [PMID: 10482435 DOI: 10.1046/j.1440-1746.1999.01956.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
655 Lin MH, Wu PY, Tsai ST, Lin CL, Chen TW, Hwang SJ. Hospice palliative care for patients with hepatocellular carcinoma in Taiwan. Palliat Med 2004;18:93-9. [PMID: 15046405 DOI: 10.1191/0269216304pm851oa] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
656 Okuaki T, Takayama Y, Nishie A, Ogino T, Obara M, Honda H, Miyati T, Van Cauteren M. T 1ρ mapping improvement using stretched-type adiabatic locking pulses for assessment of human liver function at 3 T. Magnetic Resonance Imaging 2017;40:17-23. [DOI: 10.1016/j.mri.2017.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
657 Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW. The use of conjugated hyperbilirubinemia greater than 100 μmol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. Journal of Pediatric Surgery 2007;42:359-62. [DOI: 10.1016/j.jpedsurg.2006.10.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
658 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Chongsrisawat V, Kongtawelert P, Tongsoongnoen W, Tangkijvanich P, Vejchapipat P, Poovorawan Y. Serum hyaluronan as a marker reflecting the severity of cirrhosis and portal hypertension in postoperative biliary atresia. Ped Surgery Int 2004;20:773-7. [DOI: 10.1007/s00383-004-1141-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
660 Zhong HJ, Sun HH, Xue LF, McGowan EM, Chen Y. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis. World J Gastroenterol 2019; 25(3): 378-387 [PMID: 30686905 DOI: 10.3748/wjg.v25.i3.378] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
661 Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, Sbolli G, Di Stasi M, Buscarini L. Cirrhosis of the liver. A risk factor for development of cholelithiasis in males. Dig Dis Sci 1990;35:1403-8. [PMID: 2226102 DOI: 10.1007/BF01536748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
662 Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1065-1072. [PMID: 24236690 DOI: 10.1111/jgh.12459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
663 Kim AJ, Lim HJ, Ro H, Jung JY, Lee HH, Chung W, Chang JH. Liver cirrhosis leads to poorer survival in patients with end-stage renal disease. Korean J Intern Med. 2016;31:730-738. [PMID: 27017394 DOI: 10.3904/kjim.2014.328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
664 Waziry R, Gomaa A, Waked I, Dore GJ. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era. Arab J Gastroenterol 2018;19:26-32. [PMID: 29506913 DOI: 10.1016/j.ajg.2018.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
665 Tu B, Bi J, Wu D, Zhao P, Shi L, Xie Y, Zhang X, Xu Z, Liu S, Wang X, Li X, Wang F, Qin E. Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes. Oncotarget 2018;9:35780-9. [PMID: 30515269 DOI: 10.18632/oncotarget.23200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
666 Chagas AL, Felga GEG, Diniz MA, Silva RF, Mattos AA, Silva RCMA, Boin IFSF, Garcia JHP, Lima AS, Coelho JCU, Bittencourt PL, Alves VAF, D'Albuquerque LAC, Carrilho FJ; Brazilian HCC Study Group. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival. Eur J Gastroenterol Hepatol 2019;31:1148-56. [PMID: 31247632 DOI: 10.1097/MEG.0000000000001448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
667 Richter G, Radeleff B, Stroszczynski C, Pereira P, Helmberger T, Barakat M, Huppert P. Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study. Cardiovasc Intervent Radiol 2018;41:587-93. [PMID: 29167967 DOI: 10.1007/s00270-017-1839-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
668 Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? Liver Transpl. 2010;16:964-973. [PMID: 20677287 DOI: 10.1002/lt.22093] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
669 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440. [PMID: 10573522 DOI: 10.1002/hep.510300629] [Cited by in Crossref: 1259] [Cited by in F6Publishing: 1142] [Article Influence: 54.7] [Reference Citation Analysis]
670 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
671 Cereda JM, Roulot D, Braillon A, Moreau R, Koshy A, Lebrec D. Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. J Hepatol 1989;9:246-51. [PMID: 2809166 DOI: 10.1016/0168-8278(89)90058-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [